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Keloids are exuberant and autonomous scar tissue which grossly extends 
beyond the clinical borders of the original wound. They uniquely occur in humans 
and there is no satisfactory treatment to date. There is currently no suitable animal 
model for keloid/scar research, and much is focused on understanding the 
complex molecular and cellular biology of keloid pathogenesis as a strategy to 
find appropriate therapy for this disfiguring disorder. The canonical Wnt 
signalling was recently implicated with keloid pathogenesis but it remains to be 
elucidated how this pathway is directly up-regulated at the protein level. A 
microarray study conducted within our laboratory concurred with a recent 
publication that keloid fibroblasts (KFs) have a much lower mRNA expression of 
secreted Fzd-related protein 1 (SFRP1)- a known Wnt signalling inhibitor, 
compared to normal skin fibroblasts (NFs). The work in this thesis confirmed that 
KFs indeed secrete much less SFRP1 protein compared to NFs in the conditioned 
media. It was therefore hypothesized that significant loss of SFRP1 gave rise to 
keloid pathogenesis through the up-regulation of Wnt signalling. To test this 
hypothesis, the overexpression of KFs with SFRP1 was studied and investigated 
in terms of cellular growth, migration, protein expression of extra-cellular matrix 
(ECM) components and degree of contraction in fibroblast populated collagen 
lattice (FPCL).  
Concurrently, a proteomic study performed in our laboratory detected 
Rspondin2 (Rspo2) in the conditioned media of KFs. Rspo is a relatively new 
group of secreted proteins known to be a co-activator of Wnt signalling.  This 
ix 
novel class of proteins was recently found: 1) to be implicated in epithelial-
mesenchymal interaction of the skin, 2) to promote angiogenesis and 3) to be non-
tumorigenic despite long term administration in mice. The above three points 
stated were all previously reported to be implicated or associated with keloids or 
their pathogenesis. Here, it was hypothesized that Rspo2 might have a role in 
keloid formation through the Wnt signalling pathway.  The approach for this part 
of the project was to study and compare the expression levels of Rspo2 in keloids 
and normal skin; with a focus of understanding the function of this protein in 
terms of epithelial-mesenchymal interactions.  
Finally, quercetin was tested if it had inhibitory effects on the Wnt 
signalling pathway in KFs. Quercetin, a strong dietary antioxidant, was found to 
inhibit Wnt signalling in some cancer cells, but was also previously reported to 
mitigate KFs growth and increased contraction via other signalling pathways. If it 
is found to act on the Wnt/β-catenin signalling in KFs, it would strongly suggest 
that quercetin is a suitable candidate for keloid treatment as a multi-target 
inhibitor. 
In summary, this thesis aims to show that Wnt signalling is one of the 
main modulators of keloid pathogenesis and that the upregulation of this 
canonical pathway in keloids is supported by both a negligible expression of 
SFRP1 and a higher expression of Rspo2 proteins. It is hoped that by identifying 
some of the key players of Wnt signalling in keloids, suitable therapeutic 
intervention can be identified to treat this fibrotic condition. 
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1. BACKGROUND AND SIGNIFICANCE 
1 
1.1 OVERVIEW OF NORMAL WOUND HEALING AND 
SCARRING OF THE SKIN 
 
Normal cutaneous wound healing in human skin progresses through an 
overlapping cascade of events involving inflammation, proliferation, and tissue 
remodelling (Figure 1.1).  Tissue injury initiates the inflammatory phase when the 
activation of the coagulation cascade causes release of growth factors and 
cytokines from the serum of the disrupted blood vessels and degranulating 
platelets. Blood platelets enter the wound and form a platelet plug, which together 
with the fibrin clot, work as a provisional wound matrix barrier, protecting against 
invading microorganisms. In addition, the platelets release several factors, 
including platelet-derived growth factor (PDGF) and transforming growth factor 
 (TGF-), and with the fibrin web formed, direct the migration of leukocytes 
into the wound to begin the inflammatory process. Initially, neutrophils 
[polymorphonuclear neutrophils (PMNs)] are the predominant leukocyte, but 
macrophages replace neutrophils towards the end of the inflammatory phase as 
these inflammatory cells act to debride the wound and phagocytose bacteria.  
Macrophages also serve to release several growth factors and other 
macromolecules which are required to initiate the proliferative phase of the 
healing process. 
During the proliferative phase which lasts for 3 to 6 weeks, there is 
reconstitution of the barrier and structural functions of the skin (Cheon et al., 
2005) which are associated with the epithelial and mesenchymal components of 
the wound. This proliferative phase first involves re-epithelialization in which 
keratinocytes migrate and proliferate from the wound edge. This is followed by 
2 
recruitment of fibroblasts into the wound area to synthesize a scaffold of 
reparative tissue called the extracellular matrix (ECM). This granulation tissue is 
made of procollagen, fibronectin, proteoglycans and hyaluronic acid and forms a 
structural repair framework to bridge the wound and allow vascular ingrowth 
(Slemp and Kirschner, 2006). Some of the fibroblasts subsequently differentiate 
into myofibroblasts (containing actin filaments) which help initiate wound 
contraction and closure. Once the wound is closed, the immature scar can be 
transited into the final maturation phase, tissue remodelling, which may last 
several months.  
The remodeling phase is characterized by continued collagen synthesis 
and collagen catabolism. The abundant ECM is degraded and the immature type 
III collagen of the early wound are replaced by mature type I collagen. The 
balance between synthesis and degradation of scar components shifts into a down-
regulation of healing to allow the final scar to gain maximum organization and 
strength (Niessen et al., 1999).  Any imbalance of the above either due to 
excessive matrix deposition or insufficient matrix degradation has been associated 
with the formation of keloids and hypertrophic scars (Raghow, 1994).   
In addition, the multistep process of wound healing is regulated at the 
biochemical level by a vast array of signalling mechanisms. Families of molecules 
including TGF-β, mitogen-activated protein  kinases (MAPK), and matrix 
metalloproteinases (MMPs) (Slemp and Kirschner, 2006), to name a few, all work 
together to regulate normal wound healing. These effector molecules that link the 
regulatory signals and three phases of healing are still not fully elucidated. 
3 
Similarly, any disruption or imbalance at any stage of this complex wound 
healing process will result in abnormal scar formation (Niessen et al., 1999). 
 
Figure 1.1 : The phases of cutaneous wound healing. (Adapted from Beanes et 
al. in Expert Reviews in Molecular Medicine: 
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c. Early inflammation (24 hours) d. Late inflammation (48 hours) 
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1.2 EPITHELIAL-MESENCHYMAL INTERACTIONS OF THE 
SKIN 
 
Epithelial-mesenchymal interactions are of great importance for 
organogenesis in embryonic life, and for maintenance of tissue homeostasis in the 
adult (Mackenzie, 1994). Skin tissue homeostasis in adults was previously 
demonstrated mainly by in-vitro skin models to study the interactions between 
keratinocytes (epithelial cells) and fibroblasts (mesenchymal cells). In the 
simplest form, keratinocytes and fibroblasts are co-cultured as monolayers in 
respective double chambers, separated by a semi-permeable membrane (Figure 
1.2a). The two cell types communicate in close proximity within the same culture 
media which allows the study of secretion of soluble factors that diffuse from one 
compartment to the other. 
The other intermediate model to study epithelial-mesenchymal 
interactions involves direct cell to cell contact. It was demonstrated that human 
keratinocytes proliferate when grown in direct contact with irradiated mouse 
fibroblasts (Rheinwald and Green, 1975) and human fibroblasts (Limat et al., 
1989). One of the main mechanisms elucidated using this model was the 
discovery of double paracrine signalling in epithelial-mesenchymal interactions of 
the skin. It was found that keratinocytes secrete interleukin-I (IL-1) which induces 
the production of keratinocyte growth factor (KGF) from fibroblasts; this KGF 
released in turn stimulates the proliferation of keratinocytes themselves (Maas-
Szabowski et al., 1999). 
The current most definitive model to simulate the complex in-vivo 
situation of reciprocity of the two main layers of the skin (Figure 1.2b) – 
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epidermis and dermis, is the use of organotypic skin co-culture. This model is 
becoming the standard to replace animal testing for cosmetic products. In this 
system, human skin fibroblasts are embedded in a collagen matrix (Bell et al., 
1979) to form the dermal template, and keratinocytes are seeded on top for the 
reconstitution of the epidermal layer. Studies using this organotypic skin co-
culture confirmed the need for the presence of fibroblasts to induce full 
stratification and differentiation of the epidermal layer formed by keratinocytes.  
Based on the many in-vitro co-culture studies performed as well as in-
vivo investigations of pre- and postnatal skin development, epithelial–
mesenchymal interactions are crucial in regulating skin homeostasis (Werner et 
al., 2007), part of which also involves the wound-healing response (Martin and 
Parkhurst, 2004). Interestingly, there is also increasing evidence to implicate 
epithelial–mesenchymal interactions to tumor cell progression (Mueller and 





















Figure 1.2:  In-vitro models to study epithelial-mesenchymal interactions of 
the skin.  
 (a) Co-culture of monolayer cells separated by a membrane 
(Lim et al., 2001) 
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1.3 KELOID SCARRING 
 
1.3.1 Clinical features and treatments 
 
Keloids are a form of excessive dermal fibrosis and cutaneous scarring 
thought to be caused by some kind of disorder in the regulation of cellular density 
and activity which result in the overproduction of profibrotic proteins during the 
wound healing process in predisposed individuals (Atiyeh et al., 2005; Kose and 
Waseem, 2008). Occurring only in humans, keloids are characterized by an 
overgrowth of dense fibrous tissue and higher density of blood vessels in the 
dermis (Ehrlich et al., 1994). Excessive deposition of collagen, fibronectin and 
other ECM components in keloids bring about the prominent elevation of scar 
tissue above the skin. Hypertrophic scars have similar characteristics described 
above and differentiating these two conditions can be problematic at times 
(Mustoe et al., 2002). Typically, keloids grow continuously beyond the original 
margins of the wound while hypertrophic scars stay within the boundaries of the 
original wound.  Hypertrophic scars do increase in size by pushing out the 
margins of the scar, but unlike keloids, they do not invade the adjacent dermis in 
the tissue (Peacock et al., 1970).  In addition, keloids do not regress and usually 
continue to enlarge with time (Murray, 1994). 
The keloid is a benign dermal fibroproliferative disease which does not 
expand involve structures the dermis (Le et al., 2004). Although no report thus far 
has linked keloids to any malignancies (De Felice et al., 2004), keloids often recur 
following attempted resection, disfiguring the affected individual by spreading in 
a claw-like fashion. Worse of all, keloid scarring is morbid, frequently causing 
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intolerable itching and pain, as well as restricting joint range of motion in affected 
patients (Urioste et al., 1999) which can significantly impact their quality of life.   
To date, there is no single satisfactory therapy to treat this disfiguring 
disorder (Bock et al., 2006). The numerous conventional treatments for keloids - 
surgical excision, steroid injection, radiation therapy, laser therapy, silicone and 
pressure dressings, among others - underscore how little is understood about this 
disease process (Slemp and Kirschner, 2006). Increasingly, these standard 
methods are used in combination with pharmacologic therapies, such as calcium 
channel blockers, anti-proliferative agents (5-Fluorouracil or Bleomycin), 
interferons or retinoids. Currently, such combination therapies are deemed more 
effective in the management of keloids (Al-Attar et al., 2006; Butler et al., 
2008b). As such, one of the strategies is to focus on understanding the complex 
cellular and molecular biology of keloid pathogenesis to develop the ideal 
treatment strategies.  
 
1.3.2 Histopathology of keloids 
 
Histologically, keloids and hypertrophic scars differ from normal skin 
and normal scars by their rich vasculature, increased mesenchymal cell density, 
high inflammatory-cell infiltration and thickened epidermal cell layer (Atiyeh et 
al., 2005; Kose and Waseem, 2008). In normal skin, collagen bundles in the 
dermis appear relaxed and are randomly connected to other bundles by fine 
fibrillar collagen. Collagen bundles in keloids, on the other hand are thicker and 
more abundant, yielding acellular, node-like structures in the deep dermal regions 
(Figure 1.3). The presence of large, broad and closely arranged collagen fibers 
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composed of numerous fibrils, is one of the more distinctive characteristics of 
keloids (Ehrlich et al., 1994). Keloids also have a distinct pattern of 
vascularization compared to normal skin and normal scars but the microvessels 
seem to be occluded perhaps due to the increased proliferation of endothelial cells 
(Kischer, 1992). Mast cells, macrophages and epidermal Langerhans cells have 
also been demonstrated to be elevated in keloids, but their role in keloid 
pathogenesis are not well understood.   
What is seldom highlighted is that both keloids and hypertrophic scars 
were previously reported to have thickened epidermal cell layers compared to 
normal skin and scars (Kischer et al., 1982). Thickened epidermis of hypertrophic 
scar was found to express the hyperproliferative keratins K6 and K16 (Machesney 
et al., 1998) as well as higher levels of Ki-67 at the basal layer (Andriessen et al., 
1998), indicating the presence of activated and proliferative keratinocytes in 
hypertophic scars. Similarly, our group has recently reported the observation of 










Figure 1.3:  Hematoxylin-esosin staining of normal skin and keloid scar 
tissue (10x) 
 (a) Normal skin sample (NS31) 
 (b) Keloid tissue sample (KS26) 
 
 






















1.3.3 Cytokine activation and signal transduction pathways in keloids 
 
A plethora of cellular and molecular mechanisms are linked to keloid 
pathogenesis. One of them is exaggerated cytokine activation which correlates to 
an increased risk in scar formation (Tuan and Nichter, 1998). A recent review on 
the current progress in keloid research (Butler et al., 2008a) reported that when 
compared with normal fibroblasts (NFs), a multitude of studies revealed that 
keloid fibroblasts (KFs) have increased expression of many potent cytokines, 
including TGF-, insulin-like growth factor (IGF), PDGF, and connective tissue 
growth factor (CTGF). Additionally elevated expression of IL-6 (Xue et al., 2000) 
and vascular endothelial growth factor [VEGF] (Le et al., 2004; Wu et al., 2004) 
were reported in KFs.  
In addition to increased cytokine production, KFs also increase 
transcription of the receptors for some of these factors to a substantial degree over 
NFs. This leads to aberrant healing, as the response to these factors enhances 
cellular recruitment and activation, causing excess synthesis of collagen, 
fibronectin (Kischer and Hendrix, 1983), proteoglycans, and other ECM 
components (Niessen et al., 1999; Tuan and Nichter, 1998). The increased 
activation of the various cytokines in keloids stated above has been linked mainly 
to the TGF- signal transduction pathway and in lesser instances, the IGF signal 
transduction pathway (Butler et al., 2008a). The canonical Wnt/-catenin 
signalling was reported to be involved in several fibroproliferative diseases 
(Bowley et al., 2007) and there is increasing evidence, albeit scanty, that this 
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major pathway is also implicated in keloid pathogenesis (Russell et al., 2010; 
Sato, 2006).  
 
1.3.3.1 Involvement of Wnt/β-catenin pathway in keloid pathogenesis 
 
Up-regulation of Wnt/β-catenin signalling in hypertrophic scar and KFs 
was first reported to be induced by TGF-β (Sato, 2006). While Sato showed in 
immunohistochemical studies that -catenin protein levels (downstream of Wnt 
signalling) were elevated in hypertrophic scars and keloid tissues, the paper did 
not provide evidence as to how the intrinsic canonical Wnt signalling pathway of 
keloid fibroblasts was directly activated.  This gap was partially closed in a later 
gene profiling study of normal scar and KFs which suggested that the canonical 
Wnt signalling pathway is one of the many pathways involved in the pathogenesis 
of keloids (Smith et al., 2008). The authors demonstrated how Wnt signalling can 
be involved in keloid formation when they found the gene expression of four 
inhibitors of Wnt signalling, namely dickkopf-1 (DKK1), DKK3, soluble frizzled 
related protein-1 (SFRP1) and SFRP2 decreased in KFs while expression of Wnt 
stimulating molecules, frizzled-4 (Fzd4) and disheveled-associated activator of 
morphogenesis-1 (DAAM1) were up-regulated, compared to normal scar 
fibroblasts.  These expression data were validated by using Quantitative Real-time 
PCR (Q-PCR), but unfortunately, the authors stopped short of verifying the 
fibroblasts protein expression of these Wnt inhibitors using western blots. More 
recently, the same group confirmed that proliferative keloid tissues were found to 
have decreased expression of SFRP1 and SFRP2 using immunohistochemistry 
(Russell et al., 2010). 
13 
1.3.4 Epithelial-mesenchymal interactions in keloid pathogenesis 
Keloid keratinocytes (KKs) were first found to enhance the proliferation 
of normal fibroblasts (NFs) and keloid fibroblasts (KFs) in double chamber 
serum-free in-vitro co-culture model [Figure 1.2] (Funayama et al., 2003; Lim et 
al., 2001), compared to normal kerainocyte (NK) controls in co-cultures. 
Similarly, it was found that KKs induced higher levels of both collagen I and 
collagen III in KFs compared to NK controls in the same co-culture system (Lim 
et al., 2002; Lim et al., 2003).  
Signalling pathways associated with fibrosis and proliferation were also 
found to be up-regulated due to this epithelial-mesenchymal signalling. IGF 
signalling, MAPK and phosphatidyl-inositol-3 kinase (PI-3K) pathway activation 
were observed in excessively proliferating KFs co-cultured with KKs (Lim et al., 
2003; Phan et al., 2003a) rather than with NKs. In yet another study, KKs in co-
culture with fibroblasts expressed more TGF-1, -3, and TGF-1 receptor than 
NKs; while KFs cocultured with KKs expressed more mRNA for TGF-1, -3, 
TGF-1 receptor and Smad2 compared to NFs (Xia et al., 2004). In addition, it 
was demonstrated that epidermal-dermal interactions in keloids resulted in the 
activation of the TGF-β-Smad axis by Smad 3 signalling which in turn played a 
crucial profibrotic role in keloid pathogenesis (Phan et al., 2005).  
To add on to the above examples, it was reported that there was 
modulation of yet another transcription factor STAT-3 by epithelial-mesenchymal 
interactions in keloidic cells (Lim et al., 2006, 2009). Epithelial-mesenchymal 
interaction was also implicated in the upregulation and secretion of VEGF in KFs 
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on being co-cultured with KKs (Ong et al., 2007) while biologically active CTGF 
was shown to be secreted by KFs only in the presence of overlying keratinocytes 
(Khoo et al., 2006). 
Most of the studies stated above suggest the role of abnormal 
keratinocyte-fibroblast signalling in keloid pathogenesis. In most cases, it was 
suggested that the epidermal layer of the keloid plays a pivotal role by secreting 
cytokines or signalling in a paracrine fashion to stimulate the fibroblasts in the 
underlying dermis to proliferate or produce more ECM- both of which are 
associated with excessive scar formation. Interestingly, unlike what was 
elucidated for normal skin homeostasis (see Section 1.2), no work has been 
reported on the possible double paracrine action of KKs, in which these cells 
provide a continuous feedback loop via the fibroblasts to sustain continuous 
growth for themselves. Elucidating this effect would give an insight into the 
thickened epidermal phenotype found in keloids. 
 
 
1.4 THE WNT/-CATENIN PATHWAY 
 
1.4.1 Canonical Wnt signalling 
 
The canonical Wnt signalling is one of the key signalling pathways well-
known for its major involvement in development, stem cell biology and 
carcinogenesis through the stabilization and nuclear localization of β-catenin 
(Reya and Clevers, 2005). This pathway is not commonly implicated with keloid 
pathogenesis but is linked to several other fibroproliferative diseases (Bowley et 
al., 2007).  
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There are 19 known Wnt ligands (MacDonald et al., 2009) which are 
secreted and these proteins are lipid-modified molecules. Depending on the cell 
type and receptor complement present, Wnt proteins can activate the “canonical” 
β-catenin-dependent signalling or β -catenin-independent signalling, including the 
Wnt/Ca2+ pathway and the planar cell polarity pathway. The canonical Wnt 
signalling (Figure 1.4) operates via stabilization of the transcriptional co-activator 
β-catenin. In the absence of Wnt stimulation, cytosolic β-catenin is sequentially 
phosphorylated by casein kinase I (CK1) and glycogen synthase kinase 3 beta 
(GSK3) in a complex composed of the scaffolding protein Axin and the tumor 
suppressor protein, adenomatous polyposis coli (APC). Phosphorylated β-catenin 
is recognized by the F-box protein containing slimb/ β-Trcp and degraded by the 
proteasome. The extracellular Wnt ligand initiates the signalling via its cell 
surface receptor complex, which consists of a member of the frizzled (Fzd) family 
of serpentine receptors and a co-receptor, low density lipoprotein receptor-related 
protein 5 or 6 (LRP5/6). This results in phosphorylation of dishevelled (Dvl), 
which in turn inactivates GSK3. GSK3 inactivation inhibits β-catenin 
phosphorylation and degradation, resulting in the accumulation of β-catenin, 
which translocates to the nucleus and interacts with the T-cell factor/lymphoid 
enhancer factor (TCF/LEF) family of transcription factors to activate Wnt target 
genes, such as fibronectin, cyclin D1 and c-myc.  
It has been shown however that LRP6 upon Wnt-induced 
phosphorylation, binds to Axin, thereby enabling the Wnt receptor complex to 
directly regulate β-catenin phosphorylation (MacDonald et al., 2009). In addition 
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to the Wnt family of proteins, other secreted molecules have been identified as 
ligands of LRP5/6 receptor complex and can either activate or inhibit the 
canonical Wnt/β-catenin signalling respectively. For instance, Rspondin (Rspo) 
protein was found to co-activate the Wnt/β-catenin signalling by phosphorylation 
and activation of LRP6 while DKK1, an LRP6 antagonist (or Wnt inhibitor), 
inhibits this Rspo-induced LRP6 phosphorylation. On the other hand, Wnt 
inhibitory factor (WIF) and SFRPs are secreted molecules that bind selectively to 
Wnt ligands and sequester Wnt activity through a direct interaction with the WIF 
domain and frizzled-like cysteine-rich domain, respectively. 
 































































1.4.2 Secreted Fzd-related protein 1 (SFRP1)      
 
SFRP1 is a secreted glycoprotein containing a cysteine-rich domain and 
it negatively regulates Wnt signalling at the level of the plasma membrane where 
it binds and sequesters Wnt molecules from their respective membrane receptors, 
the Fzd family. Loss of SFRP1 expression has been observed in many tumors, 
including cancers of the kidney, colon, lung, ovary and breast (Gumz et al., 
2007). In general, it has been accepted that Wnt/β-catenin suppression is the 
mechanism by which SFRP1 inhibits tumour cell growth and prevents metastatic 
invasion (Esteve and Bovolenta, 2010). For example, a breast cancer cell line, 
MDA-MB-231 had reduced proliferation and lower migratory ability when 
treated with exogenous SFRP1 or when SFRP1 was re-expressed in this cell line 
ectopically (Matsuda et al., 2009). 
More recently, down-regulation of SFRPs was implicated with fibrosis. 
Increased bone morphogenetic protein (BMP) signalling was reported to play a 
role in collagen biosynthesis (He et al., 2010) and in fibrotic diseases such as 
fibrodysplasia ossificans progressiva (Kaplan et al., 2009). SFRP1 and SFRP2 
were found to inhibit BMP signalling(Misra and Matise, 2010) and administration 
of exogenous SFRP2 in a myocardial infarction rat model reduced fibrosis (He et 
al., 2010).  In keloids, SFRP1 was reported to be down-regulated at the mRNA 
level in their fibroblasts (KFs) compared to normal scars fibroblasts (Smith et al., 
2008). Immunohistochemical examination revealed that in active areas of keloid 
tissue, there were decreased SFRP1 and SFRP2 expression as well as increased 
expression of insulin-like growth factor binding protein 5 (IGFBP5), a profibrotic 
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factor. Inhibitor study using Trichostatin A (TSA) and 5-aza-2’-deoxycytidine (5-
aza-dC) on KFs suggested a role for differential histone acetylation of the SFRP1 
gene that regulates SFRP1 expression in keloids and that silencing of SFRP1 may 
be an important fibrosis signature shown by KFs (Russell et al., 2010) .  
However, no work has been reported on the stable re-expression of 
SFRP1 in KFs to determine if KFs’ phenotype can be reverted to that of NFs in 
terms of cell proliferation, cell migration and degree of contraction in fibroblast 
populated collagen lattice (FPCL), unlike studies which were performed in 
cancers (Gumz et al., 2007; Huang et al., 2007). A study as such would give 
further insight on the mechanisms leading to keloid formation and suggest 
strategies to treat or prevent keloids. 
 
1.4.3 Rspondin (Rspo) proteins 
 
Rspondin (Rspo) is a relatively new group of secreted proteins known to 
be an activator or a co-activator of the canonical Wnt signalling pathway.  They 
were reported to synergize with the Wnt proteins to activate -catenin (Kim et al., 
2006). Rspo1 was first identified in the developing spinal cord of mouse, and its 
expression requires Wnt activities (Kamata et al., 2004). In Xenopus, Rspo2 was 
isolated in a functional cDNA expression screen for molecules that can activate 
TCF/ β-catenin dependent reporter expression in HEK293T cells (Kazanskaya et 
al., 2004). As observed in the mouse, Xenopus R-spondin genes are often co-
expressed with and induced by Wnt genes during embryogenesis. Human Rspo1 
has the ability to promote, upon over-expression in transgenic mice, robust 
proliferation of intestinal epithelial cells (Kim et al., 2005). Rspo1 was also found 
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to be effective in preventing intestinal mucositis and oral mucositis caused by 
cancer chemotherapy in a mouse model (Zhao et al., 2009). In the same study, it 
was also reported that Rspo1 and Rspo2 did not promote tumorigenesis or its 
progression in a human carcinoma xenograft model despite high dose and long-
term administration. In humans, mutations in Rspo1 gene caused defects in 
epidermal growth and differentiation of the skin through epithelial-mesenchymal 
signalling (Parma et al., 2006). In addition, recombinant human (rh) 200ng/ml of 
Rspo2 protein was shown to promote proliferation and sprouting angiogenesis in-
vitro in human endothelial cells via VEGF signalling (Kazanskaya et al., 2008).  
Some of the above findings on Rspo coincide with certain aspects 
associated with keloid formation, namely, the epithelial-mesenchymal signalling 
in the skin and angiogenesis via VEGF.  The hyperplastic but non-tumorigenic 
nature of Rspo1 and Rspo2 is similar to keloid formation, which is a benign 
dermal fibroproliferative skin disorder with no malignant potential (Atiyeh et al., 
2005). Furthermore, Rspo2 was expressed in conditioned media (CM) of KFs in a 
proteomic study performed in our laboratory (Han, 2007). It is therefore 
hypothesized that Rspo proteins, in particular Rspo2 might have a role in keloid 




Quercetin is the most common of the flavonoid glycones found in the 
diet and the richest sources of this compound are onions, apples, and red wine 
(Hertog et al., 1993a; Hertog et al., 1993b; Kuhnau, 1976). Quercetin has a wide 
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range of biologic activity including anti-viral, anti-inflammatory, and anti-
microbial properties. This strong dietary antioxidant causes cell cycle arrest in 
human leukemic T cells (Yoshida et al., 1992), keratinocytes (Beniston and 
Campo, 2003; Lee at al., 2005) as well as human breast, gastric and ovarian 
cancer cells (Scambia et al., 1990; Bischoff 2008). Quercetin also induces 
apoptosis through a pathway involving heat shock proteins (Wei et al. 1994) and 
down-regulates the mutant p53 gene (Bischoff 2008). More recently, quercetin 
was found to be a potent inhibitor against Wnt/β-catenin/TCF signalling in 
SW480 colon cancer cells (Park et al., 2005) as well as in acute lymphoblastic 
leukemia cell lines (Kawahara et al., 2009). 
Results from previous studies in our laboratory have demonstrated that 
quercetin exhibited strong inhibitory effects on KFs proliferation and their 
contractile ability in FPCL (Phan et al. 2003d). Additionally, quercetin inhibited 
collagen production by suppressing the IGF-1 (Phan et al., 2003c) and TGF-β 
(Phan et al., 2004) signalling pathways. For epidermal cells of the human skin, 
quercetin was reported to inhibit cellular growth in HaCaT (Lee et al., 2005) and 
primary foreskin keratinocytes (Beniston and Campo, 2003). 
On the basis of the above results, it is hypothesized that quercetin might 
target the elevated levels of canonical Wnt signalling in keloids. If quercetin, a 
known multi-target or broad spectrum kinase inhibitor (Kerr and La Thangue, 
2004) is further proven to target Wnt signalling in keloidic cells and their in-vitro 
culture model, it could potentially be developed as a therapeutic agent to treat 
keloid scarring. 
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1.6 OBJECTIVES OF PRESENT STUDY 
The broad objective of this study aims to show that the canonical Wnt 
signalling pathway is one of the main modulators of keloid pathogenesis and that 
the up-regulation of this signalling in keloids is supported by both a negligible 
expression of SFRP1 and a higher expression of Rspo proteins respectively.  
The specific objectives of this study are as follows: 
1. To investigate the direct effects of Wnt signalling on keloid fibroblasts, 
compared to normal fibroblasts  
2. To verify the down-regulation of SFRP1 protein in keloid fibroblasts at 
mRNA as well as protein level and investigate how stable transduction of 
SFRP1 can revert their fibrotic phenotype to that of normal fibroblasts. 
3. To determine the expression levels of Rspo proteins in primary cultures of 
keloid compared to normal skin and investigate Rspo’s role in keloid 
pathogenesis, with a focus on epithelial-mesenchymal interactions. 
4. To test if quercetin has inhibitory effects on the fibrotic phenotype of in-




















































2.1  PATIENTS’ SAMPLES AND ISOLATION OF THEIR 
FIBROBLASTS AND KERATINOCYTES 
 
Keloid samples were taken from patients who had received no previous 
treatment before surgical excision. A full history was taken and physical 
examination performed before taking informed consent prior to excision. Normal 
skin samples were taken from tissues excised from non-keloid-forming 
individuals in plastic surgery procedures. These tissues were donated for research 
with informed consent.  Brief details of the donor and site of tissue origin are 
given in Table 1. NS denotes normal skin; KS, keloid skin; NFs, NKs, normal 
skin fibroblasts, keratinocytes; and KFs,KKs, keloid fibroblasts, keratinocytes 
respectively. Approval by the National University Hospital’s (NUH) Institutional 
Review Board (IRB) and SingHealth Centralised IRB (IRB#121/2008, 
2009/548/D and 2009/550/D) were given for the collection and use of human skin 
tissues and cells for this research. 
To isolate keratinocytes, an area up to 4 cm2 of normal skin or keloid 
tissue was immersed in 2.5mg/ml of Dispase II (Roche) in DMEM (Dulbecco’s 
Modified Eagle Medium from Gibco) and left overnight at 4oC. The epidermis 
was subsequently scraped off with a scalpel with care and incubated in a solution 
of 0.25% trypsin (Gibco) and 0.02% ethylene diamine tetra-acetic acid (EDTA 
from JT Baker) for 10 minutes. On observation of intercellular separation, trypsin 
action was inactivated with 10% FCS (Fetal Calf Serum from Gibco). These 
isolated cells were transferred into tubes and centrifuged at 1300 rpm for 5 
minutes, re-suspended and seeded into culture flasks for further culturing. 
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For fibroblast isolation, the skin samples were further cut into small 
pieces of 2-3 mm2 which were then transferred to a new 100mm tissue culture 
dish coated with a thin layer of culture media (DMEM/10%FCS) to facilitate 
adherence of the tissue pieces on the culture plate surface. Additional culture 
media enough to cover the explants was added and topped up after 2 to 3 days for 
the fibroblasts to outgrow from the cut tissues.  
 














Normal skin     
NS31 F Malay 13 Groin 
NS35 F Indian 33 Breast 
NK/NF103 M Chinese 1 Hand 
NK111 M Chinese 29 Forearm 
NS/NF112 F Chinese 35 Breast 
NK/NF114 M Malay 50 Thigh 
NS115 F Caucasian 10 Abdomen 
NS121 M Chinese 54 Eyelid 
NK0131 M Chinese 1 Back 
NK0428 M Chinese 28 Scalp 
NK0601 M Chinese 39 Back 
NFcj9 M Chinese 18 Eyelid 
NFcj12 F Chinese 20 Eyelid 
NFE1 M Indian 22 Forearm 
NKFS1 M Chinese 13 Groin 
NFM06 M Malay 26 Groin 
NFM84 M Malay 8 Foreskin 
NFM94 M Malay 12 Foreskin 
NK/NFS05 F Malay 25 Breast 
NK/NFS06 M Chinese 22 Abdomen 
     
Keloid     
KF12 F Chinese 20 Earlobe 
KK24 F Chinese 23 Earlobe 
KS/KF26 M Chinese 36 Forearm 
KS31 F Chinese 17 Earlobe 
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KS43 M Chinese 34 Elbow 
KS46/KF46 M Chinese 36 Forearm 
KS/KK/KF48 F Indian 23 Earlobe 
KF49 F Malay 28 Earlobe 
KS50 M Chinese 32 Upper Back 
KS56 F Chinese 22 Earlobe 
KS101/KK101 M Chinese 27 Right Wrist 
KF110 M Malay 9 Left Cheek 
KK111 F Chinese 21 Right Back 
KFS01 F Malay 16 Earlobe 
KFS04 M Chinese 17 Earlobe 
KKST08/ 
KFST08 
F Chinese 24 Earlobe 
 
 
2.2 CULTURE OF PRIMARY CELLS AND CELL LINES 
 
Keratinocytes were cultured according to Rheinwald’s and Green’s 
method (Rheinwald and Green, 1975). Briefly, keratinocytes were cultured on a 
feeder layer of lethally irradiated 3T3-J2 (a kind gift from Prof. H. Green, 
Harvard Medical School, Boston, MA) at 60Gy using a Cobalt 60 gamma 
irradiator (JL Shepherd) at a density of 5 x 104 cells/cm2 in culture media. The 
culture media consists of DMEM and Ham’s F12 (Gibco) media (3:1 mixture) 
containing 10% FCS (Hyclone), 5mg/ml insulin (Sigma), 0.18mM adenine 
(Calbiochem), 0.4mg/ml hydrocortisone (Calbiochem), 0.1nM cholera toxin 
(Sigma), 2nM triiodothyronine (Sigma), 10ng/ml epidermal growth factor 
(Upstate) and 100 IU–100 mg/ml penicillin–streptomycin (1x P/S - Gibco). 
Alternatively, the keratinocytes were cultured in a serum and feeder free system 
using Epilife media with supplements (Cascade Biologics) and 1x P/S.  
Skin fibroblasts, 293T cells and control L-cells were maintained in 
DMEM/10% FCS/1x P/S while Wnt3a secreting L-cells were cultured in the same 
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media with 350g/ml of G418. All culture conditions were maintained in 5% CO2 
atmosphere at 37°C.  
For all primary cultures of keratinocytes and fibroblasts, cells from the 
second to the fifth passages were used for all experiments. 
2.2.1 Conventional and modified conditioned media (CM) from Wnt3a-
secreting L-cells and control L-cells 
 
Wnt3a-secreting L-cells and control L-cells in respective T150 flasks 
(80-90% confluent) were subcultured in the ratio of 1:10 into new T150 flasks 
and maintained in DMEM/10% FCS without antibiotics at 37oC for 4 days. This 
was followed by the same fresh media change and the media conditioned for 
another 3 days. The first and second batches of the CM were combined, steri-
filtered and stored at either 4oC or -30oC, ready to be used for treatment of 
fibroblasts. This conventional way of preparing media conditioned with Wnt3a-
secreting L-cells are termed Wnt3a L-cell CM and for L-cells - L-cell CM which 
serves as a control to Wnt3a L-cell CM treatment for all experiments (Ueda et al., 
2002). 
For the preparation of modified CM, Wnt3a-secreting L-cells and 
control L-cells were similarly subcultured in the ratio of 1:10 in T150 flasks and 
maintained in DMEM/10% FCS at 37oC for 4 days according to the supplier’s 
specification. In this instance, the second batch of fresh media change was 
modified to either serum free (SF) DMEM or SF basal keratinocyte medium 
(BKM) and conditioned for another 3 days before collection. BKM was modified 
based on MCDB153 (Boyce and Ham, 1983), and consisted of DMEM-F12 
mixture (3:1) added with the following supplements from Sigma unless otherwise 
27 
stated - 5g/ml insulin, 0.4g/ml hydrocortisone (Calbiochem), 2nM tri-
iodothyronine, 0.1mM ethanolamine, 0.1mM phosphoryl ethanolamine, 2nM 
progesterone and 0.18mM adenine (Calbiochem). Media conditioned with this 
modified method in Wnt3a L-cells are termed Wnt3a L-cell-SF DMEM, or Wnt3a 
L-cell BKM; in control L cells - L-cell-SF DMEM or L-cell BKM.  The Wnt3a 
activity of Wnt3a L-cell-CM and Wnt3a L-cell-BKM were verified on HEK293T 
cells (Figure A1 in Appendix) using luciferase reporter assays. 
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2.3 KERATINOCYTE–FIBROBLAST DOUBLE CHAMBER CO-
CULTURE 
 
NKs or KKs were seeded at a density of 105 cells/cm2 on Transwell clear 
polyester membrane inserts with 0.4μm pore size and an area 4.5 cm2 (Corning-
Costar). The cells were maintained for 4 days in Epilife with full supplements 
until 100% confluent. Epilife was subsequently supplemented with increased 
calcium concentration and the cells exposed to the air–liquid interface for another 
3 days, bringing about keratinocyte stratification and terminal differentiation. 
Respective NFs or KFs were seeded in six-well plates at a density of 105 
cells/well in DMEM/10% FCS/1xP/S for 48 hours to 80% confluence. 
Keratinocytes on membrane inserts and plated fibroblasts were washed twice with 
phosphate buffered saline (PBS) before the inserts were fitted into the fibroblast 
cultures to initiate the co-culture phase in fresh SF DMEM (Figure 1.2a). At day 
3, cells and their CM were collected and analysed separately. 
 
2.4 EXOGENOUS TREATMENT OF FIBROBLASTS AND 
KERATINOCYTES WITH REAGENTS 
 
2.4.1 Treatment of NFs, KFs, NKs and KKs with L-cell CM, Wnt3a L-cell 
CM and recombinant proteins  
 
The cells were seeded in respective plates at densities between 5 x 103 to 
2.5 x 104 cells per cm2 in respective growth media. 24 hours after cell attachment, 
media was changed to SF medium for another 24 to 48 hours for cells to achieve a 
basal state or for transient transfection. For fibroblasts, these cells were 
subsequently treated with conventional L-cell-CM and Wnt3a L-cell CM or the 
modified L-cell-SF DMEM and Wnt3a-L-cell-SF-DMEM. For keratinocytes, 
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these cells were similarly treated with the modified L-cell BKM. and Wnt3a-L-
cell BKM. For the above two cells types, rhRspo2 (50ng/ml and 250ng.ml) and 
rhDkk1 at 200ng/ml would be added as appropriate in some of the experiments 
for the purpose of cellular growth assays, luciferase reporter assays and Western 
blot analyses. 
 
2.4.2 Treatment with quercetin 
 
KFs exposed to conventional Wnt3a L-cell CM and NKs exposed to 
Wnt3a-L-cell-BKM with 50ng/ml of Rspo2 were subjected to quercetin exposure 
at concentrations of 5 and/or 20 g/ml. For evaluation of collagen lattice 
contraction (see sections 2.12 and 2.12.1), quercetin at 20 g/ml was added into 
the culture media 1 day after NKs were seeded on the lattices. As quercetin was 
diluted with dimethyl sulfoxide (DMSO, Sigma) which serves as a vehicle, equal 
volumes of DMSO were also added in tests without quercetin in the same 
experiments. 
 
2.5 PREPARATION OF EXPRESSION AND REPORTER 
PLASMIDS FOR TRANSFECTION 
 
Expression plasmids - pCMV6-SFRP1 and pCMV6-Rspo2 with 
Myc/Flag tag at the C-terminal and their control plasmid, pCMV6-Entry vector 
(Figure 2.1) were all purchased from Origene Technologies. TOPflash and 
FOPflash (both from Upstate) while Super8xTOPflash and Super8xFOPflash 
(both were gifts from Prof David M. Virshup’s laboratory, Duke-NUS Graduate 
Medical School, Singapore) are plasmids which are reporters of β-catenin/TCF-
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induced transcriptional activity (Veeman et al., 2003). -galactosidase-expressing 
vector was obtained from Iqbal Dulloo (National Cancer Centre, Singapore). 



































The respective plasmid DNA was transformed into competent E. Coli 
(DH5alpha or HB101). 50μl of these cells were thawed, incubated on ice with 1μl 
plasmid DNA for 20 minutes, heat shocked for 30 seconds at 37oC and then 
placed on ice for another 2 minutes. Subsequently, 1ml of luria broth (LB) was 
added and the total content transferred to round bottom tube to be shaken at 37oC 
for 1 hour in an incubator. 10 to 100μL of the broth was spread on the appropriate 
selective plates. These plates were incubated overnight at 37oC. 
 
2.5.2 Plasmid Purification and DNA sequencing 
 
Single bacterial colonies were picked from fresh plates the day after 
transformation into the required volume of LB containing the appropriate 
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selection antibiotics (100μg/ml ampicillin or 50μg/ml kanamycin) and shaken 
overnight at 37oC.  The following day, specified volumes of the transformed 
bacteria in LB were frozen in 15% of glycerol while the remaining volumes were 
used for isolation of the respective plasmid DNA by Miniprep (Qiagen) according 
to the manufacturer’s protocol. Only expression plasmids obtained were sent for 
sequencing at 1st Base Pte Ltd (Singapore). The sequence information was 
analyzed using Chroma 2.13 software (Technelysium Pty Ltd, Australia). 
Sequence alignments were performed with tools from the BLAST website 
www.ncbi.nlm.nih.gov/blast/bl2seq/wblast2.cgi and Clustal website 
www.ebi.ac.uk for multiple sequence alignment. The sequence alignments and 
result summaries for human SFRP1 and Rspo2 are shown in Tables A1 and A2 in 
Appendix. 
After confirmation that the desired DNA expression was correct, 
Maxiprep (Qiagen) was performed on the same frozen transformed bacteria stock 
amplified in required volumes of LB with appropriate selection antibiotics 
according to the manufacturer’s protocol. 
 
2.5.3 Transient transfection of DNA into HEK293T cells 
 
HEK293T cells were transiently transfected with human SFRP1 and 
Rspo2 to be used as positive controls for protein expression studies. The 
expression plasmids used were pCMV6-hSFRP1 and pCMV6-hRspo2 with 
Myc/Flag tag at the C-terminal while the control plasmid used was pCMV6-Entry 
vector (Figure 2.1). All transfections were performed using Lipofectamine/Plus 
reagent (Invitrogen Technology), according to the manufacturer's instructions. 
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Briefly, 2×105 cells were seeded in 6-well plates in DMEM/10% FCS. The 
following day, 0.5μg of the respective expression plasmids was added to a 
mixture of DMEM, Plus reagent and Lipofectamine and this mixture was used to 
replace the growth media in the plates for transfection. After 3 hours of 
transfection, cells were incubated in SF DMEM for another 24 hours. The cells 
were harvested and CM collected for further Western blot analyses. 
 
2.5.4 Luciferase reporter assay of activation of -catenin/TCF- 
transcriptional activity of HEK293T cells, fibroblasts and 
keratinocytes 
 
2×105 of HEK293T cells, NFs, KFs or NKs were seeded in 6-well plates 
in respective growth media. On the following day, these cells were transiently 
transfected using Lipofectamine/Plus reagent (Invitrogen Technology) with either 
TOPflash and FOPflash reporters (2μg each) or Super8xTOPflash and 
Super8xFOPflash (2g each) reporters in conjunction with -galactosidase-
expressing vector (0.5g) as an internal control. 24 hours post-transfection, these 
cells were treated with respective test media. The cells were then lysed 24 hours 
later and both luciferase and -galactosidase activities were determined by a 
luminometer (EG&G Berthold Lumat LB 9507). The luciferase activity was 
normalized to the -galactosidase activity. 
 
2.6 LENTIVIRAL TRANSDUCTION 
 
2.6.1 Transduction of SFRP1 into KFs and Rspo2 into NFs 
 
EMW-SFRP1 and EMW-Rspo2 was assembled by cloning of SFRP1 
and Rspo2 genes respectively into parent lentiviral vector EMW (a kind gift from 
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Zhao Jing, Cambridge) encoding internal ribosomal entry site (IRES)-linked 
green fluorescent protein (GFP). 
pCMV6-hSFRP1 (Origene Technologies) was digested with FseI and 
the ends of the fragment was blunted using Klenow enzyme. The fragment was 
then digested with BamHI. EMW vector was digested with XhoI, treated with 
Klenow enzyme and subsequently digested with BamHI. The SFRP1 gene was 
cloned into the EMW vector and the sequence of the correct clone was verified by 
sequencing.  
Similarly, Rspo2 fragment, obtained from pCMV6-hRspo2 (Origene 
Technologies), was amplified using polymerase chain reaction (PCR) with 
addition of BamHI restriction stie at the 5’end and XhoI at the 3’end of the gene. 
The digested fragment was ligated to BamHI/XhoI digested vector backbone and 
transformed into DH5alpha competent cells. The correct clone was sequenced to 
verify that the Rspo2 was free of mutation.  
Lentiviral vectors were produced by transient transfection of HEK293T 
cells. Approximately 5x106 cells (per plate) were seeded in 10-cm tissue culture 
plates 24 hours before transfection. Packaging virus with the gene of interest was 
performed using the calcium phosphate precipitation method with 10 mg pWPT-
DSRed2 vector, 7.5 mg helper plasmid pPax2, and 2.5 mg of MD2G envelope 
plasmids (gifts from Dr. D. Trono, University of Geneva, Geneva, Switzerland). 
Cells were replaced with fresh media at 14 to 16 hours after transfection. The 
supernatant was filtered through a 0.45-mm filter, and the titer of supernatant on 
293T cells was determined using flow cytometry. NF and KF cells were infected 
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with unconcentrated lentiviral supernatant at a MOI of 5-10 and average 
transfection efficiency in these primary cells was about 80% when observed with 
a Zeiss Axioplan fluorescent microscope. 
 
2.6.2 Transduction of β-catenin short interfering RNA into NKs 
 
Bacteria stocks of four different targets against -catenin (Genbank 
Accession number NM_001904) cloned in a pLKO.1 vector were obtained from 
Sigma. These bacteria stocks were expanded and their respective plasmids were 
obtained using a midiprep kit (Qiagen). The sequences of the four targets, named 
-cat shRNA sequence 1 to 4 as well as the scrambled sequence are shown in 
Table 2.2. 
The pLKO.1-TRC empty vector along with the same vector cloned with 
scrambled sequence and -cat shRNA sequences were transfected into 293T-
based amphotropic packaging cell line for 12 hours. The lentiviruses were 
harvested at 24 and 48 hours respectively and filtered through a 0.45 µm cellulose 
acetate membrane. The lentiviral supernatant was aliquoted, frozen at -80oC and 
thawed only before infection of NKs. The NKs were infected overnight in the 
presence of 4 µg/ml polybrene, and replaced with fresh media of respective 
treatment regimes. 
 

























2.7 ANALYZING mRNA EXPRESSION OF FIBROBLASTS AND 
KERATINOCYTES 
 
2.7.1 RNA extraction from cultured cells 
 
Total RNA extracts were extracted from NF, KF, NK and KK cells 
using TRIzol reagents (Invitrogen Technology) to solubilize their respective cell 
pellets. Glycogen was added to increase the yield of RNA. Proteins were first 
removed by chloroform extraction and the aqueous layer containing the nucleic 
acids was isolated using Maxtract low and high density gel (Qiagen). RNA 
extracts were precipitated with equal volumes of isopropanol and centrifuged at 
11,000g for 15mins at 4oC. The pellets were washed twice in 80% diethyl 
pyrocarbonate (DEPC)-ethanol and subjected to clean-up using the RNeasy Mini 
Kit (Qiagen) according to manufacturer’s instructions. The resulting RNA 
extracts were treated with RNase free DNase (Qiagen) to remove all traces of 
DNA. Concentrations of the RNA extracts were measured using a Nanodrop 
spectrophotometer (ND-1000). The final RNA extracts were either stored at -80oC 
for future use or used immediately for complementary DNA (cDNA) synthesis. 
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2.7.2 Complementary DNA (cDNA) synthesis  
 
1μg of total RNA was reverse-transcribed to cDNA using the 
Superscript III first strand synthesis system (Invitrogen Technology) according to 
the following: 
1g of RNA    : Volume depends on RNA concentration 
Primer (OligoDT)  : 1 μl 
10mM dNTP mix  : 1 μl 
PCR-grade water  : Top to 10μl 
  
The above reaction was incubated at 65oC for 5 minutes and then placed on ice 
for 1 minute. 
 
Master mix reaction prepared for each reaction was as follows: 
 
Reaction mix from above   : 10μl 
10x reverse transcription (RT) buffer  : 2μl 
25mM MgCl2     : 4μl 
0.1m DTT     : 2μl 
RNase Out      : 1μl 
Superscript III RT    : 1μl 
 
This second reaction mix was incubated at 50°C for 50 minutes followed 
by incubation at 85°C for 5minutes. 1μl of RNase H was added to remove the 
RNA primers followed by incubation at 37°C for 20 minutes. cDNA products 
were then stored in -30°C and to be used for polymerase chain reaction (PCR) and 
quantitative Real time-PCR (Q-PCR). All reaction incubations were performed in 
DNA Engine Peltier thermal cycler (Biorad). 
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2.7.3 Polymerase chain reaction (PCR) 
 
1μl of cDNA template was amplified in a 25μl reaction volume using 
Platinum PCR SuperMix High Fidelity (Invitrogen) and primers as follows: 
SuperMix   : 22μl 
Primer, forward  : 1μl 
Primer, reverse  : 1μl 
cDNA sample   : 1μl 
 
Thermal cycling was performed in the DNA Engine Peltier thermal cycler 
(Biorad), with the following conditions: 
50ºC for 30 minutes, 94ºC for 5 minutes 40 seconds 
58ºC for 40 seconds, 72ºC for 1 minute 30 seconds 
35 cycles 
72ºC for 10 minute 
4ºC  
 
Sequences for PCR primers used are shown in Table 2.3. The fidelity of the 
reverse transcription-PCR products were verified by comparing their size with the 
expected cDNA bands visualized on a 1.8% agarose gel. 
Table 2.3: PCR primer sequences 
 
Gene (Human)  Primer sequence 
Forward 5’-ACA GAC ACA AGA CAC ACA CGC-3’ 
Rspo1 
Reverse 5’-TGT CTT CTG GTG GCC TCA G-3’ 
Forward 5’-CCG AGC CCC AGA TAT GAA C-3’ 
Rspo2 
Reverse 5’-TGA CCA ACT TCA CAT CCT TCC-3’ 
Forward 5’-GCC AAG GTC ATC CAT GAC AAC-3’ 
GAPDH 
Reverse 5’-GTC CAC CAC CCT GTT GCT GTA-3’ 
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2.7.4 Quantitative Real time PCR (Q-PCR) 
 
Q-PCR was performed using the LightCycler 480 (Roche) on a mixture 
of cDNAs, required primers and SYBR Green I Master (Roche) dye according to 
the manufacturer’s recommendation. Reactions were performed in 10μl reaction 
volumes as follows: 
Master Mix (per reaction): 
Sybr Green Master Mix  :  5μl 
Primer (Forward+Reverse, 10μM) :  1μl 
PCR-grade water   :  3.5μl 
cDNA (200ng)   : 0.5l 
 
For each gene, the master mix was prepared for triplicate reactions and 
aliquoted into 384-well plates for measurements. The fold change values between 
keloid and normal samples were calculated using Ct method (Livak and 
Schmittgen, 2001). GAPDH was used as an internal control and genes of interest 
are listed in Table 2.4.  
 
Table 2.4: SYBR Green Real-Time PCR primer sequences 
 
 
Gene(Human)  Primer sequence 
Forward 5’-CAA GAA GAA GAA GCC CCT GA-3’ 
SFRP1 
Reverse 5’-AAG TGG TGG CTG AGG TTG TC-3’ 
Forward 5’-GGC CCA GAC CCA ACT ATG ATT AG-3’ 
CCN2 
Reverse 5’-CTG CAG GAG GCG TTG TCA TT-3’ 
Forward 5’-CAA AGG TCC CCG TGG TGA GA-3’ 
COL1A1 
Reverse 5’-CAG CAA TAC CTT GAG GCC CG-3’ 
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Forward 5’-GCG CCG GCT GTG CTG CAC AGG-3’ 
FN1 
Reverse 5’-GCC TGG GGA CAG CGG TGC CC-3’ 
Forward 5’-GCC AAG GTC ATC CAT GAC AAC-3’ 
GAPDH 
Reverse 5’-GTC CAC CAC CCT GTT GCT GTA-3’ 
 
 
2.8 PROLIFERATION AND VIABILITY ASSAYS OF 
FIBROBLASTS AND KERATINOCYTES 
 
Skin fibroblasts and keratinocytes were seeded at a density of 1x104 
cells per well onto 24-well plates or 3x103 cells per well onto 96-well plates with 
respective growth media. 24 hours after cell attachment, media was changed to 
basal media for another 24-48 hours. This was to allow the cells to achieve a basal 
state. The cells were subsequently treated with respective test media as well as 
their positive control media (DMEM/10% FCS for fibroblasts and Epilife for 
NKs).   
For cellular growth/proliferation, cells were assessed using the 
colorimetric CellTiter 96 AQueous One Solution Cell Proliferation Assay kit 
(Promega) at Days 1 to 4 after 4 hrs of incubation on a photometric plate reader 
(BIO-RAD, Benchmark PlusTM). The kit consists of a tetrazolium compound, 
MTS and an electron coupling reagent which together form a stable solution. The 
quantity of formazan product formed, measured by the amount of 490nm 
absorbance is directly proportional to the number of living cells in culture.  
In certain experiments, cell viability was tested using propidium iodide 
(PI) staining based on 10 000 cells acquired per sample on a flow cytometer 
(Beckman Cyan ADP). 
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2.9 MIGRATION ASSAY AND LIVE CELL TIME-LAPSE IMAGING 
 
Migration assay was performed using the scratch method and live cell 
time-lapse imaging.  NFs and KFs were grown to confluency in a 12-well plate 
before a scratch wound was manually introduced into each well using a yellow 
pipette tip. The cultures were washed twice with PBS, replaced with fresh control 
L-cell CM and Wnt3a L-cell CM. The plate was subsequently transferred to an 
incubating chamber (5% CO2 37°C) within a Nikon Eclipse C1 Plus Confocal 
Microscope (Nikon, USA) for time-lapse imaging. Images of cell migration were 
taken at 30-minute intervals for duration of 24 hours, collected and analysed with 
NIS-Elements software (Nikon, USA). Cell migration was measured by percent 
closure of the scratch zone selected, as follows: 
Percent closure (%) = Migrated Cell Surface Area/Total Surface Area x 100 
 
 
2.10 HISTOLOGICAL METHODS 
 
2.10.1 Paraffin embedding and sectioning 
 
Skin, keloid tissues and organotypic skin cultures were fixed for 24 
hours in formalin in preparation for paraffin section. Samples were then 
dehydrated by successive incubations in increasing concentrations of (50%, 70%, 
80%, 95% and 100%) ethanol solution (Merck) for 45 minutes each; this was 
done with gentle agitation on a shaker. This was followed by two incubations in 
xylene (Merck) solution for 15 minutes each. Samples were then placed onto 
plastic cassettes and transferred into 60°C liquid paraffin tank (Leica) for 30 
minutes. Samples were embedded and left to solidify on the -5°C cold plate. 5 to 
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8μm thick sections were prepared using a microtome (Leica) and placed onto 




Organotypic skin cultures were embedded in tissue freezing media 
(Leica) in a plastic holder, wrapped in aluminium foil and snap-frozen at -150oC. 
The frozen tissue block was either kept at -80oC for sectioning at a later date or 
the block was sectioned to between 5 to 8μm thickness and placed onto polylysine 
coated glass slides. The sectioning was performed in a cryostat machine 
(Microme HM550, GMBH) which was cooled to -20oC. 
 
2.10.3 Hematoxylin and Eosin (H&E) staining 
 
Paraffin was dissolved by heating slides at 50°C on a heating plate 
followed by immersion of slides in xylene for 10 minutes. Sections were re-
hydrated by successive incubations in decreasing concentrations (100%, 95%, 
80% and 50%) of ethanol solutions. Slides were immersed in hematoxylin 
solution (Sigma) for 3 minutes and the stains were washed off immediately with 
running tap water followed by immersion in Scott’s tap water for 2 minutes. Next, 
the slides were immersed in eosin Y solution (Sigma) for 30 seconds and 
dehydrated in a series of ethanol of increasing concentrations (95% and 100%) 
followed by final two immersions into xylene solution for 10 minutes each. For 
mounting, a drop of Permount mounting solution (Fisher Scientific) was spread 
onto the sections, covered with a coverslip and allowed to dry overnight. The 
stainings were visualized with a Zeiss Axioplan microscope (Carl Zeiss). 
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2.10.4 Immunohistochemistry (IHC) 
 
Serial paraffin sections of normal skin and keloids (5µm thick) were 
dewaxed in xylene and then hydrated in descending concentrations of ethanol. 
Antigen retrieval was done by immersing the slides in 0.01 M Tris /0.001M 
EDTA buffer (pH9.0) and pressure-cooked for 5 minutes. All sections were 
cooled under running tap water for 10 minutes. The Dako Envision+ kit was used 
for subsequent IHC steps. Briefly, endogenous peroxidase was blocked using 3% 
H2O2 for 30 minutes and washed in TBS-Tween 20 for 3 times. Non-specific 
binding was blocked using the Dako Protein Block, serum-free, for 5 minutes, 
followed by washes in TBS-Tween 20 for 3 times. Subsequently, sections were 
incubated with monoclonal anti-active β-catenin (Millipore), anti-Ki67 (Dako) or 
polyclonal anti-Rspo2 (R&D systems) in dilutions of 1:200 overnight.  
After washing in TBS-Tween 20 3 times, the slides were incubated in 
secondary mouse antibody from the Dako Envision+ kit for 1 hour. The slides 
were washed sequentially and incubated with 3,3-diaminobenzidine (DAB) for 5 
minutes. Subsequently, the slides were counterstained with Gill’s III hematoxylin, 
dehydrated in ascending concentrations of ethanol, and cleared in xylene. Finally 
the sections were mounted using Depex (Merck).  Non-immunised mouse 
antibody (IgG) was used for negative controls. The stainings were visualized with 






Immunostaining was performed on cell cultures in 8-well Lab-Tek 
Chamber slides with covers (Nalge Nunc) or cryosection slides with skin 
organotypic cultures. The slides were washed with PBS and fixed with 4% 
paraformaldehyde for 15 minutes at 4oC. The sections were subsequently blocked 
for 30 minutes with 5% normal goat serum in PBS. Ki67 (MIB-1) monoclonal 
antibody (1:100, DAKO) in PBS containing 5% goat serum was applied to the 
slides for 2 hours at room temperature followed by secondary antibody 
conjugated with Alexfluro-568 (1:500, DAKO) in PBS containing 5% goat serum 
for another hour at RT. After washing the slides with PBS, the cell nuclei were 
counter-stained with 4,6-diamidino-2-phenylindole (DAPI). The stainings were 
visualized with a Zeiss Axioplan fluorescent microscope (Carl Zeiss). 
 
 
2.11 WESTERN BLOTTING 
 
2.11.1 Protein extraction from tissue culture cells 
 
Cell pellets or cells on plates were washed with PBS to remove any 
remnants of serum.and lysed directly in RIPA lysis buffer (Santa Cruz) containing 
protease inhibitors. 1 ml of the buffer was used to lyse 2x107 of cells in 
suspension or 0.6 ml of the buffer used - to lyse a subconfluent monolayer of 
adherent cells on a 10cm-plate. Cells were solubilized by passing solution through 
the pipette tip repeatedly followed by incubation on ice for 15 minutes. Samples 
were then centrifuged at 4°C, 12,000g for 10 minutes and the supernatant 
containing the proteins were collected as total cell lysates (CLs).  
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As for isolation of cytoplasmic extracts of cultured cells, Pierce 
NE_PER Cytoplasmic Extraction Reagents (Thermo Scientific) were used 
according manufacturer’s instructions.  
All the proteins extracted were quantified and/or stored at -80°C for 
further protein analysis. 
 
2.11.2 Concentration of conditioned media (CM) 
CM of respective cell monocultures and co-cultures were diluted at least 
two times with distilled water before being concentrated using Amicon Ultra-4 PL 
10 or Amicon Ultra-15 PL 10 centrifugal filters (Millipore). The protein 
concentrates were quantified and/or stored at -80°C for further protein analysis. 
  
2.11.3 Determination of protein concentrations 
 
Protein concentrations of total CLs, cytoplasmic lysates and CM were 
determined using the Pierce Bicinchoninic Acid Protein (BCA) Assay Reagent 
(Thermo Scientific) according to manufacturer’s instructions. A standard curve 
was prepared using bovine serum albumin (BSA) with concentrations ranging 
from 0-2000μg/ml in RIPA lysis buffer. Five and ten fold dilutions were carried 
out for each sample and 4 repeats were done for each standard or sample. 200μl of 
colorimetric assay reagent was added to each well. After the 96-well plate was 
incubated at 37°C for 30 minutes, protein concentrations were assayed by 
measuring absorbance at 570 nm with a reference wavelength of 690nm, using a 
photometric plate reader (BIO-RAD, Benchmark PlusTM) 
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2.11.4 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Sodium Dodecyl Sulphate (SDS)-polyacrylamide protein separations 
were performed using the Protean II or III system (BIO-RAD). The separation 
gels (8% and 12%), depending on the molecular weight of the protein of interest 
as well as stacking gels were cast according to the composition shown in Table 
2.5. After the gels were solidified, the comb was removed from the stacking gel 
and the wells rinsed by de-ionised H2O (dH2O). Samples containing 20 to 60μg of 
protein were mixed with SDS-PAGE loading buffer (Table 2.6), boiled for 5 
minutes at 95°C and cooled down on ice immediately to prevent renaturation of 
proteins. Subsequently, these samples were loaded into individual wells of the 
stacking gel. 10μl of protein standard (BIO-RAD) was loaded in one lane for each 
run. Gels were run at an initial 80 volts past the stacking gel after which voltage 
was increased to 120 volts in running buffer using a PowerPac Universal machine 
(BIO-RAD).  
 
Table 2.5: Composition of stacking and separation gels for electrophoresis 
 
 Stacking gel 
(10ml) 
8% separation gel 
(20ml) 
12% separation gel 
(20ml) 
30% Acrylamide 1.4ml 5.3 8 
10% SDS 100μl 200μl 200μl 
10% Ammonium 
Persulfate (APS) 100μl 100μl 100μl 
TEMED 10μl 10μl 10μl 
1.5M Tris/HCl pH 6.8 2.5ml - - 
0.5M Tris/HCl pH 8.8 - 5ml 5ml 
50% glycerol - 1ml 1ml 
dH2O 6ml 5ml 2.5ml 
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Table 2.6: Composition of self-prepared reagents for western blotting 
 
Reagent Composition 
SDS-PAGE loading buffer 2% SDS, 0.01% bromophenol blue, 10% glycerol, 100mM DTT 
Running buffer 25mM Tris, 192mM Glycine, 0.1%SDS 
Transfer buffer 10mM Tris, 75mM Glycine, 10% methanol 
Tris buffered saline (TBS) 10mM Tris, 150mM NaCl 
TBST or Wash buffer TBS with 0.1%(v/v) Tween 20  
Blocking buffer 5% (w/v) skimmed milk in TBST 
Incubation Buffer 1% (w/v) skimmed milk in TBST 
 
 
2.11.5 Protein electroblotting (Protein transfer) 
 
Nitrocellulose membrane, blot absorbent filter papers and sponges (all 
from BIO-RAD) were pre-soaked in transfer buffer. The gel with the separated 
proteins from the “SDS-PAGE” casing was transferred onto the nitrocellulose 
membrane in the sandwich configuration shown in the transfer stack (Figure 2.2). 
Care was taken to avoid bubbles during the stacking. The entire assembly was 
placed in the gel tank with transfer buffer and protein electroblotting (transfer) 
performed at 250mA for 120 minutes in a cold room. After the run was 
completed, the nitrocellulose membrane was stained with Ponceau (Sigma) to 
ensure proper and complete transfer. 
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Figure 2.2:  Transfer stack 
 
2 x filter papers
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2.11.6 Blocking, antibody incubation, washing and stripping 
After the Ponceau stain was rinsed off with washing buffer, the 
membrane was incubated in blocking buffer at room temperature for 1 hour. 
Primary antibodies were subsequently prepared in incubation buffer according to 
their respective dilution factors shown in Table 2.7. The blocked membrane was 
incubated with the diluted primary antibody in adequate volume of buffer at 4°C 
overnight. The following day, the membrane was washed 5 times- each time 10 
minutes with washing buffer and incubated in sufficient volume of buffer diluted 
with horseradish peroxidase (HRP)-coupled secondary antibody at room 
temperature for 1 hour. The membrane was washed again with washing buffer for 
5 times before incubation with Western lightning plus-ECL (Perkin Elmer) for a 
minute, exposed on X-ray films (Konica Minolta) and developed. For the purpose 
of reprobing, antibodies were stripped from the membrane with Restore stripping 
buffer (Thermo Scientific) for 10 minutes and re-blocked with blocking buffer. 




Table 2.7:  Details of antibodies and their dilution factor used for 
immunoblotting 
 
 Antibody Source Dilution factor 
Primary β-catenin -polyclonal Cell signaling 1:1000 
 β-tubulin - monoclonal Sigma 1:1000 




 Collagen I,II,III MONOSAN 1:500 




 Fibronectin Epitomics 1:5000 




 LRP6 (C5C7) -monoclonal Cell signaling 1:500 
 PCNA (C-20) -polyclonal Santa Cruz 
Biotechnology 1:1000 
 phospho-LRP6 (Ser1490) - 
polyclonal 
Cell signaling 1:500 
 VEGF (A20) - polyclonal Santa Cruz 
Biotechnology 
1:500 
 Rspo2 -polyclonal R&D systems 1:500 
 SFRP1 - polyclonal R&D systems 1:500 













2.12 ORGANOTYPIC SKIN CO-CULTURE 
 
The organotypic skin co-cultures consist of a cellular (fibroblasts) 
collagen matrix and an upper layer of epidermal layer (keratinocytes) as shown in 
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Figure 1.2b. Protocols for preparation of this co-culture constructs were adopted 
from those described by Vaccariello and colleagues (Vaccariello et al., 1998) with 
modification in terms of keratinocytes culture and their media used.  For 
submerged keratinocytes for growth, medium and additives used were based on 
Rheinwald’s and Green’s method (Rheinwald and Green, 1975) as described in 
Section 2.2. When the keratinocytes were lifted to air-liquid interface (ALI) for 
differentiation, the medium consisted three parts DMEM/one part Ham’s F12 
supplemented with 10% FCS, 0.1 nM cholera toxin, 0.4 mg/ml hydrocortisone 
and 50μg/ml ascorbic acid (Smola et al., 1998). 
Cellular collagen matrices were cast using 10X DMEM, L-glutamine, 
FCS (all from Invitrogen Technology), sodium bicarbonate, rat tail acid-extracted 
collagen Type 1 (3.3mg/ml) solution (BD Biosciences) and NFs suspension (or 
NFs stably transduced with Rspo2 or its control) at a concentration of 5 x 105 
cells/ml of fibroblast media. The above components were mixed thoroughly and 
these aliquots were added to each Transwell polycarbonate membrane insert with 
3μm pore size of 12-well or 6-well plates (Corning-Costar) and allowed to 
polymerize as fibroblast-populated collagen lattices (FPCLs). 5 x 105 
keratinocytes were seeded on the collagen gel after 2 days, cultured for 4 days and 
submerged before raising the inserts to ALI for 8 days. 
 
2.12.1 Evaluation of FPCL contraction 
 
The lattices with and without keratinocyte seeding were measured for 
their diameters by scanning the dish into a computer and measuring the diameters 
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at stipulated time points. The average area was calculated from the diameters and 
expressed as a percentage of initial lattice area. 
Percentage of initial area = A2/A1 × 100, 
 
where A1 = initial gel area and A2 = area of gel at the observed interval. 
 
 
2.12.2 Measurement of epidermal thickness in organotypic cultures 
 
The organotypic cultures at Day 8 after exposure to ALI were fixed with 
10% buffered formalin, embedded in paraffin, sectioned and stained with H&E. 
The slides were observed under a Zeiss Axioplan microscope (Carl Zeiss) to 
determine the epidermal layer thickness of the organotypic cultures. 3 separate 
measurements were made using the internal calipers of the AxioVision software 
on the microscope. The values for each organotypic culture were averaged to give 
an average thickness for each specimen.  
 
2.13 QUANTIFICATION AND STATISTICAL ANALYSIS 
 
Relative integrated densities of protein expression in Western blots were 
quantified using ImageJ 1.43m (US National Institutes of Health). All statistical 
analyses in the entire study were performed using GraphPad InStat version 3.06 
(GraphPad Software, USA) using one-way Anova - Student-Newman-Keuls 
multiple comparisons tests or Student’s t-tests (two tailed). A p-value of less than 






































3.1 WNT SIGNALLING AND ROLE OF SFRP1 IN 
BEHAVIOUR OF KELOID FIBROBLASTS  
 
3.1.1 Activation of Wnt/β-catenin signalling was enhanced in KFs 
compared to NFs after Wnt3a treatment 
 
Figure 3.1.1 demonstrated that β-catenin/TCF-induced transcriptional 
activity was higher in KFs compared to NFs after Wnt 3a CM treatment. The 
above results were confirmed by western blot analyses of their β-catenin 
expression. While it was observed that Wnt3a CM increased β-catenin expression 
in both NFs and KFs relative to its control media (L-cell CM), KFs generally 
expressed higher levels of β-catenin compared to NFs (Figure 3.1.2) for both 
types of treatment. Taken together, the results suggest that there is higher 
amplification of Wnt/-catenin signalling in KFs compared to NFs.  
 
3.1.2 Increase in cellular growth and fibronectin expression were more 
pronounced in KFs compared to NFs after Wnt3a treatment 
 
As Wnt/-catenin signalling was reported to promote cellular growth 
and proliferation in fibroblasts (Baksh and Tuan, 2007; Torii et al., 2008; Yun et 
al., 2005), Wnt3a was used to test if it would similarly bring about enhanced 
growth in both NFs and KFs. 
First, it was demonstrated using MTS assay (Figure 3.1.3a) that there 
was more pronounced increase (dotted line for NFS05 versus solid line for 
KFS04) in Day-4 cellular growth in KFs compared to NFs after treatment with 
Wnt3a (relative to control L-cell CM). Statistical comparison of percentage 
increase in cellular growth in both types of fibroblast (3 lines in each group) after 
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Wnt3a treatment (Fig. 3.1.3b) revealed that the increase in cellular growth of KFs 
was significantly higher (p<0.01). 
Next, in western blot analyses, while higher expression of proliferating 
cell nuclear antigen (PCNA) was observed in both NFs and KFs after Wnt3a 
treatment (Figures 3.1.4a-b), the quantified relative integrated densities showed 
that the level of PCNA increase was higher and more significant in the KF group 
(p<0.01 for KFs versus p<0.05 for NFs, n =3). Similarly, it was observed that the 
increase in protein expression of fibronectin was significant only in KFs but not in 
NFs. However, no significant change was observed in protein expression of 















Figure 3.1.1:  Luciferase activity of NFs and KFs co-transfected with 
reporter gene constructs with TOPflash(2μg) or its mutant 
FOPflash(2μg) and β-galactosidase plasmid (0.5μg) as an 
internal control. Ratios of luciferase/ β-galactosidase 
activities after treatment with L-cell CM and Wnt3a L-cell 
CM represent β-catenin/T-cell factor (TCF)-induced 













































Figure 3.1.2:   Western blot showing expression of β-catenin in NFs and 
KFs (2 representative lines in each group) treated with L-
cell CM and Wnt3a L-cell CM; relative integrated densities 
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Figure 3.1.3 (a) Day-4 MTS assays of representative lines of NF (NFS05) 
and KF (KFS04) treated with control L-cell CM and Wnt3a 
L-cell CM; absorbance values represent mean +/- SD of 
quadruplicates. (b) Percentage increase of Day 4 MTS 
absorbance values in NFs and KFs (3 different lines in each 
group) due to Wnt3a L-cell CM treatment relative to control 
L-cell CM treatment; values represent mean +/- standard 
error of means (SEM) of percentage change (n=3 each). 
Statistical analyses were performed using Student’s t-test (2-
















































































Figure 3.1.4 (a) Western blot showing expression of PCNA, fibronectin, 
collagen I and GAPDH in representative lines of NF 
(NFS05) and KF (KFS04) after 2-day treatment with serum 
free DMEM, L-cell CM and Wnt3a L-cell CM. (b) Average 
relative integrated densities of PCNA/GAPDH, 
fibronectin/GAPDH and collagen I/GAPDH expression in 
western blots of NFs and KFs (3 different lines in each 
group) treated with same sequence of culture media shown 
in Fig. 3C; values represent mean +/- SD. Statistical analyses 
were performed using one-way Anova- Student-Newman-


























































































































































































3.1.3 Wnt3a induced marginally higher degree of contraction of both NF- 
and KF- populated collagen lattices (PCLs) compared to control CM 
 
In general, it was observed that with or without Wnt3a treatment, the 
degree of contraction in KF-PCLs were higher than NF-PCLs (3 lines in each 
group), concurring with several earlier reports (Hasegawa et al., 2005; Phan et al., 
2003b; Phan et al., 2003d). While Wnt3a L-cell CM was able to bring about 
higher degree of contraction in both NFs-PCLs and KFs-PCL compared to L-cell 
control CM (3 lines in each group and in duplicates for each treatment), the 
difference was insignificant (Figure 3.1.5).  
Figure 3.1.5:   (a) Images of FPCLs incorporated with representative lines 
of NF (NFS06) and KF (KFS01) at 48 hours after treatment 
with L-cell CM and Wnt3a L-cell CM respectively. (b) 
Average percentage of FPCL contraction by NFs and KFs (3 
different lines in each group) after 48 hours treatment with 
control L-cell CM and Wnt3a L-cell; values represent mean 
+/- SD. Statistical analyses were performed using Student’s 
t-test (2-tailed) with ****p<0.0001. 
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3.1.4 Marginal decrease in cell migration rate was observed in NFs and 
KFs after Wnt3a treatment  
 
Cell migration and closure in scratch test assays were shown in 
representative lines of NF and KF at T=0 and T=24 hours in Figure 3.1.6a. 
Analyses of the area of cell closure after migration for both NFs and KFs revealed 
that in general, KFs had a higher migration rate compared to NFs, concurring with 
previous reports (Fujiwara et al., 2005; Lim et al., 2006). As shown in Figure 
3.1.6b, Wnt3a brought about a marginal decrease in cell migration for both NFs 
and KFs, starting at T=6 hours. However, this difference brought about by Wnt3a 
treatment was not significant at all time points based on Student’s t-test (two 
tailed) analysis. 
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Figure 3.1.6:   (a) Phase contrast images of representative lines of NF 
(NFS06) and KF (KFS01) in scratch test assay at T = 0 and 
T = 24 hours after treatment with L-cell CM and Wnt3a L-
cell CM; scale bar = 200μm. (b) Average percentage of 
scratched area closed after treatment with control L-cell 
CM and Wnt3a L-cell CM on NFs and KFs (3 different lines 
in each group) from T = 0 to T = 24 hours measured at 6-
hour intervals; values represent mean +/- SD. 
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3.1.5 SFRP1 was immuno-detected at 34kDa in CM of transfected 
HEK293T cells 
 
The specificity of SFRP1 antibody (R&D systems) was confirmed in 
CM of HEK293T cells transiently transfected with Myc/Flag-tagged SFRP1 
construct and probed with both c-Myc and SFRP1 antibodies. Expression of 





Figure 3.1.7: Western blot showing expression of c-myc and SFRP1 in 
CM of HEK293T cells transiently transfected with pCMV6-
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3.1.6 SFRP1 expression levels were suppressed in KFs 
 
mRNA expression of SFRP1 was found to be down-regulated on the 
average by 85 times in the KF group compared to the NF group (p<0.05 for n=3 
in each group) when analysed by Q-PCR method (Figure 3.1.8a). Concurrently, 
mRNA expression of collagen, type 1, alpha 1 (COL1A1), fibronectin 1 (FN1) and 
connective tissue growth factor (CCN2) were also analysed for both types of 
fibroblast which re-affirmed the phenotype of KFs in this study. The tested KFs 
expressed significantly higher levels of the above-stated pro-fibrotic factors. KFs 
were previously reported to be up-regulated for COL1A1 (Kauh et al., 1997; Uitto 
et al., 1985; Uzawa et al., 1998), FN1 (Babu et al., 1989; Kischer and Hendrix, 
1983) and CCN2 (Igarashi et al., 1996; Xia et al., 2007).  
In western blot analyses of NFs and KFs (3 lines in each group), higher 
expression of SFRP1 was observed in CM of NFs compared to KFs (Figure 
3.1.8b).   
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Figure 3.1.8:  (a) mRNA fold change of NFs and KFs (3 different lines in 
each group) for expression levels of SFRP1, COL1A1, FN1 
and CCN2 analysed by Quantitative Real time PCR. All 
values represent mean +/- standard deviation (SD) and p 
values obtained were based on unpaired Student’s t-test (2-
tailed) analysis (n=3 each) with *p<0.05 and ***p<0.005. (b) 
Western blot showing expression of SFRP1 in CM of NFs and 
KFs with CM of HEK293T transfected with 1μg of pCMV6-










































































3.1.7 Stable transfection of SFRP1 in KFs 
 
Figure 3.1.9a confirmed the stable transduction of a representative line 
of KF (KF12) using lentivirus encoding GFP (EMW). Western blots in the same 
figure showed that SFRP1 protein was highly secreted in 3 lines of KF transduced 
with lentivirus encoding GFP and SFRP1 (EMW-SFRP1) compared to their 
controls (EMW only). However, only KFS01 and KF12 expressed slightly lower 
levels of -catenin after the SFRP1 transduction as shown by Western blot 
(Figure 3.1.9b).  
 
Figure 3.1.9:  (a) Fluorescence microscopy of a representative line, KF12 
stably expressed with EMW-SFRP1 and EMW constructs 
respectively. Both EMW constructs contain GFP tags which 
indicate that the cells were more than 90% transfected; scale 
bar = 100μm. Next, western blot showing expression of 
SFRP1 in CM of KFS01, KFS04 and KF12 over-expressed 
with EMW and EMW-SFRP1 constructs respectively. (b) 
Western blot showing expression of -catenin in total CLs of 
KFS01, KFS04 and KF12 transfected with EMW and 
EMW-SFRP1 constructs; relative integrated densities of the 
















































































































































3.1.7.1 KFs transduced with SFRP1 displayed reduced cellular growth and 
viability 
 
MTS assays performed on these stably tranduced fibroblasts at Day 4 
also showed that 2 lines of KFs - KFS01 and KF12 with ectopic expression of 
SFRP1, displayed significantly lower cellular growth (Figure 3.1.10a) compared 
to their controls. These results corresponded to the reduction in β-catenin 
expression observed in these two lines (Figure 3.1.9b). However, PI staining 
assays (Figure 3.1.10b) performed on all 3 lines of SFRP1-transduced KFs based 
on GFP-positive population, showed that the overall average cell viability of these 
cells was significantly lower than their control counterparts (p<0.05).  Western 
blot analyses showed that all KFs transduced with SFRP1 expressed lower levels 
of PCNA compared to their controls (Figure 3.1.10c) with KFS04 showing the 
least decrease. A similar trend of protein down-regulation of cyclin D1 was seen 
in both KFS01 and KF12 with KFS04 being the exception. 
In addition, when treated with Wnt3a L-cell CM, the reduced cellular 
growth observed after ectopic expression of SFRP1 became significant in KFS04 
while in KF12, the effect was more significant at p<0.01 (Figure 3.1.10d) when 





Figure 3.1.10:  (a) Day-4 MTS assays of KFS01, KFS04 and KF12; 
absorbance values represent mean +/- SD (n=6 each group). 
(b) Average percentage of viable cells from 3 lines of KFs 
transduced with EMW and EMW-SFRP1 based on 
propidium iodide (PI) staining in flow cytometry performed 
in tri-plicates, expressed by mean percentage +/- SEM (n=9). 
(c) Cyclin D1 and PCNA - western blot showing expression 
of total CLs from KFS01, KFS04 and KF12 transfected with 
EMW and EMW-SFRP1 constructs; relative integrated 
densities were quantified using ImageJ software. (d) Day-4 
MTS assays of KFS04 and KF12 after culture in control L-
cell CM and Wnt3a L-cell CM respectively; absorbance 
values represent mean +/- SD (n=4 each group).  All 
statistical analyses above were performed using Student’s t-















































































































































































































































































3.1.7.2 KFs transduced with SFRP1 displayed reduced expression of 
fibronectin but not collagen I 
 
Western blot analyses in Figure 3.1.11a showed that there was down-
regulation of fibronectin in the SFRP1-transduced KFs with KFS01 exhibiting the 
maximum decrease while there was only marginal decrease in KFS04.  However, 
there was no change in collagen I expression in all the SFRP1-transduced KFs 
compared to their controls. In addition, it was observed that there was wider 
reduction of fibronectin expression in SFRP1-transduced KFS04 as well as in 
SFRP1-transduced KF12 when they were treated with Wnt3a L-cell CM (Fig. 
3.1.11b). 
Figure 3.1.11:   (a) Western blot showing expression of fibronectin and 
collagen I in total CLs of KFS01, KFS04 and KF12 
transfected with EMW and EMW-SFRP1 constructs. (b) 
Western blot showing expression of fibronectin in CLs of 
KFS04 and (c) KF12, transfected with EMW and EMW-
SFRP1 constructs after 3-day culture in control L-cell CM 
and Wnt3a L-cell CM respectively. All relative integrated 











































































































































































































































3.2 ROLE OF RSPONDIN2 (RSPO2) IN WNT SIGNALLING OF 
KELOIDS  
 
3.2.1 mRNA expression of Rspo2 was found in KFs but not in KKs 
 
mRNA expression of Rspo1 and Rspo2 were analysed using semi-
quantitative reverse transcription-PCR (RT-PCR) for 3 different lines of cultured 
NFs, NKs, KFs and KKs. Both NFs and KFs were found to express Rspo1 and 
Rspo2 respectively (Figure 3.2.1a) while all NKs and KKs did not express Rspo2 
(Figure 3.2.1b). However, some of the NK and KK cultures were found to express 
Rspo1.  
 
Figure 3.2.1:   mRNA expression of Rspo1 and Rspo2 in monocultures of (a) 
normal and keloid fibroblasts; (b) normal and keloid 
keratinocytes; analyzed using reverse transcript PCR, 
visualized on 1.8% agarose gel and quantified for their 
relative integrated density using ImageJ software. HEK293T 
cells were used as positive controls (PC) and negative controls 
(NC) were without template cDNAs. All values represent 
means +/- SEM with n=3. 
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3.2.2 Rspo2 was immuno-detected at 35kDa in total CLs and CM of 
transfected HEK293T cells 
 
The specificity of the relatively new RSPO2 antibody (R&D systems) 
was confirmed in total CLs and CM of HEK293T cells transiently transfected 
with Myc/Flag-tagged Rspo2 construct and probed with both c-Myc and Rspo2. 
The molecular weight of Rspo2 in these over-expressed CLs and CM was found 
to be 35kDa (Figure 3.2.2a-b). 
 
Figure 3.2.2:   Overexpression of Rspo2 in HEK293T. pCMV6-Entry control 
vector and pCMV6-Rspo2 plasmid with Myc/Flag tag were 
transiently transfected into HEK293T cells.  Expression of c-
myc and Rspo2 were probed in Western blots of their (a) total 



































































3.2.3 Increased protein expression and secretion of Rspo2 in respective 
monocultures of KF and KK  
 
Higher expression of intracellular Rspo2 was observed in monocultures 
of KF compared to NF (Figure 3.2.3a) while there was marginal expression of 
Rspo2 in total CLs of KKs(Figure 3.2.3b). Total CLs of NK had negligible 
protein expression of Rspo2 similar to its mRNA expression (Figures 3.2.3b and 
3.2.1b). Secreted Rspo2 was found in serum-free (SF) KF CM but not detected in 




Figure 3.2.3:   Western blot showing expression of Rspo2 in equal amounts - 
40μg (a) total CLs from NF and KF monocultures. (b) Total 
CLs from NK and KK monocultures. 10μg of HEK293T 
transfected with 1μg of pCMV6-Rspo2 plasmid was used as 
positive control (PC). Relative integrated densities of the 
western blot bands were quantified using ImageJ software 
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Figure 3.2.4:   Western blot showing expression of Rspo2 in equal amounts - 
60μg (a) CM from both monocultures of NF and KF. (b) CM 
from monocultures of NK, co-cultures of NK/NF and NK/KF. 
(c) CM from monocultures of KK, co-cultures of KK/KF and 
KK/NF. CM of HEK293T transfected with 1μg of pCMV6-
hRspo2 plasmid was used as positive control (PC). Relative 
integrated densities of the western blot bands were quantified 
using ImageJ software where necessary. All values represent 
means +/- SEM with n=3 or n=4. p values are indicated based 
on unpaired student t-test (2-tail); *p<0.05 is significant. 
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(c) KK KK/KF KK/NF  
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3.2.4 KKs in epithelial–mesenchymal interactions increased protein 
expression and secretion of Rspo2 
 
KKs but not NKs, upregulated the expression of Rspo2 in NFs (p<0.05) 
and KFs in the double co-culture chamber (Figures 3.2.5a-b). Likewise, NFs or 
KFs did not have an effect on the expression levels of Rspo2 in CLs of NK or KK 
respectively in the co-culture model (Figures 3.2.5c-d).  
In the CM, KK-NF and KK-KF combinations brought about an increase 
in secretion of Rspo2 as higher expression of this protein were observed 









Figure 3.2.5:   Western blot showing expression of Rspo2 in equal amounts - 
40μg (a) total CLs from NF in co-cultures. (b) total CLs from 
KF in co-cultures. (c) total CLs from NK in co-cultures. (d) 
total CLs from KK in co-cultures. 10μg lysate from HEK293T 
cells transfected with 1μg of pCMV6-hRspo2 plasmid was used 
as positive control (PC). Relative integrated densities of the 
western blot bands were quantified using ImageJ software 
where necessary. All values represent means +/- SEM with n=3. 
p values are indicated based on unpaired student t-test (2-tail); 
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3.2.5 Rspo2 induced proliferation of keratinocytes but not of dermal 
fibroblasts 
 
Enhanced fibroblast proliferation is a characteristic of keloid tissue 
(Calderon et al., 1996; Lim et al., 2006). Here the possible proliferative effect of 
rhRspo2 (used singly or in combination with Wnt 3a CM) was investigated on 
NFs or KFs.  It was observed by Day 4 that while SF Wnt3a CM alone elicited 
proliferation in the fibroblasts, Rspo2 (up to 250ng/ml) alone did not induce any 
proliferative effect. Rspo2 in combination with Wnt3a, however, brought about a 
significant increase in proliferation (p<0.05) (Figure 3.2.6a) in KFs.  
However, in NKs, rhRspo2 brought about an increase in proliferation in 
a dose dependent fashion and the proliferation rate was significantly higher 
(p<0.05) at Day 4 with a dose of 250ng/ml (Figure 3.2.6b) compared to the use of 
basal media. In addition, rhRspo2 was found to synergize with Wnt3a to bring 
about a significant enhancement in proliferation (p<0.01) compared to using 
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Wnt3a CM alone.  The proliferative effect of rhRspo2 on NKs was confirmed 
















Figure 3.2.6:   MTS assay of (a) a representative strain of normal fibroblasts 
(NFS05) and keloid fibroblasts (KF26) treated for 4 days with 
L-cell-SF DMEM, rhRspo2 (50ng/ml or 250ng/ml) in L-cell-SF 
DMEM, Wnt3a L-cell-SF DMEM, rhRspo2 (50ng/ml) in 
Wnt3a-L-cell-SF DMEM and DMEM with 10%FCS. (b) a 
representative strain of normal keratinocytes (NK2412) treated 
for 2 and 4 days with L-cell BKM, rhRspo2 (50ng/ml or 
250ng/ml) in L-cell BKM and Wnt3a L-cell BKM, rhRspo2 
(50ng/ml) in Wnt3a L-cell BKM; additional treatment of 
rhDkk1 (200ng/ml) was used to treat 2 sets of the keratinocytes 
incubated with 250ng/ml of rhRspo2 in L-cell BKM and 
rhRspo2 (50ng/ml) in Wnt3a L-cell BKM respectively.  All 
values represent means +/- SD of quadruplicates.  Statistical 
analysis was performed using one-way Anova - Student-
Newman-Keuls Multiple Comparisons Test; *p<0.05, **p<0.01 
and ***p<0.001. (c) Normal keratinocytes (NKS05) seeded in 
Lab-Tek 8-well chamber slides after 2-day treatment with L-
cell-BKM, rhRspo2 (250ng/ml) in L-cell BKM and Wnt3a L-
cell BKM, were immunostained with monoclonal anti-Ki67 and 
4,6-diamidino-2-phenylindole (DAPI). Scale bar = 100μm.  (d) 
Western blot showing expression of PCNA in NKS05 after 2-
day treatment with BKM, L-cell BKM, rhRspo2 (250ng/ml) in 
L-cell BKM, Wnt3a L-cell BKM and rhRspo2 (50ng/ml) in 
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3.2.6 Rspo2 activated Wnt/β-catenin signalling in cultured NKs and it 
acts synergistically with Wnt3a through phosphorylation of co-
receptor LRP6 
 
NKs transiently transfected with the Wnt/-catenin signalling reporter 
construct 8xSUPERTOPflash (Veeman et al., 2003) were found to be activated 
for luciferase activity in an increasing fashion starting with rhRspo2 alone 
(250ng/ml), Wnt3a CM alone and finally rhRspo2 (50ng/ml) used in combination 
with Wnt 3a CM (Figure 3.2.7a). The result indicated that Rspo2 activated Wnt/-
catenin signalling in keratinocytes and that it acts synergistically with Wnt 3a to 
bring about this activation. 
Western blots of NK cytosolic extracts treated with Rspo2 or/and Wnt 
3a CM for 4 hours, probed for -catenin also verified the activation of the Wnt/-
catenin signalling as rhRspo2 was observed to stabilize cytosolic -catenin and it 
synergized with Wnt3a to induce accumulation of -catenin in keratinocytes 
(Figure 3.2.7b).  
LRP6 was reported to be phosphorylated in Rspo-mediated Wnt/-
catenin signalling in HEK293T (Kim et al., 2008; Wei et al., 2007) and C2C12 
cells (Lu et al., 2008) respectively. NK was tested to determine if there was a 
similar effect and it was found that rhRspo2 did not elicit significant 
phosphorylation of LRP6 in keratinocytes. However, when used in conjunction 
with Wnt 3a CM, phosphorylation of LRP6 was elevated compared to Wnt3a CM 
treatment alone. Use of rhDkk1, a known Wnt/-catenin signalling and LRP6 
antagonist (Bafico et al., 2001; Mao et al., 2001), inhibited the LRP6 



















Figure 3.2.7:   (a) Luciferase activity of normal keratinocytes (NK0131) co-
transfected with reporter gene constructs with TCF-4 binding 
sites- 8×SUPERTOPflash (2μg) or a mutant TCF-binding site-
8×SUPERFOPflash (2μg), respectively, and -galactosidase 
plasmid (0.5μg) as an internal control in each well. 24 hours 
after incubation, the cells were treated with BKM, L-cell-BKM 
and Wnt3a L-cell BKM with or without rhRspo2 as indicated. 
Ratios of luciferase/-galactosidase activities were used to 
obtain values of relative luciferase activity and were 
represented by mean +/- SD of duplicates. (b) Western blot 
showing expression of -catenin in cytosolic extract of NK0428 
after 4-hour treatment with L-cell-BKM, rhRspo2 (250ng/ml) 
in L-cell-BKM, Wnt3a L-cell-BKM and rh Rspo2 (50ng/ml) in 
Wnt3a L-cell-BKM. (c) Western blot showing expression of -
catenin, phosphorylated LRP6 and total LRP6 in total CLs of 
NK0428 pretreated with or without rh Dkk1 (200ng/ml) for 2 
hours in BKM, followed by incubation in L-cell-BKM, rhRspo2 
(250ng/ml) in L-cell-BKM, Wnt3a L-cell-BKM and rhRspo2 
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3.2.7 Stable silencing of -catenin in NKs 
 
To further confirm whether Wnt/-catenin signalling is involved in NK 
proliferation, NKs were infected with lentivirus expressing -catenin shRNA. All 
four of the different targets for -catenin displayed satisfactory suppression of -
catenin expression in NKs (Figure 3.2.8).   
Figure 3.2.8:   Western blot showing expression of -catenin of total CLs of 
untreated NK0131 as well as NK0131 stably transfected with 
control pLKO.1-TRC vector, pLKO.1-TRC vectors cloned 
with scrambled sequence and four targets of -catenin short 













3.2.7.1 Keratinocyte proliferation by Rspo2 and its synergistic effect with 
Wnt3a were mediated through the Wnt/β-catenin pathway 
 
In the MTS proliferation assay, the addition of Dkk1 impeded the 
proliferation rate of NKs treated with Rspo2 alone, and when used in combination 
with Wnt 3a (Figure 3.2.6b). This suggests that the proliferation of NKs induced 
by Rspo2 as well as the enhanced proliferation due to its synergistic effect with 
Wnt3a, were activated through the Wnt/-catenin signalling pathway. 
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In addition, NKs transduced with lentivirus expressing β-catenin shRNA 
(Figure 3.2.8), expressed lower levels of PCNA, compared to the same cells 
infected with scrambled sequence after treatment with Rspo2 or/and Wnt3a 
(Figure 3.2.9).  
Figure 3.2.9:   PCNA protein expression of NK0131 transfected with 
scrambled sequence and sequences 1 and 2 were treated with 
fresh replacement media of L-cell BKM and Wnt3a-L-cell 
BKM with or without Rspo2. 
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3.2.8 Analysis of normal skin, keloids and organotypic skin cultures  
 
3.2.8.1 Higher expression of Rspo2 and active β-catenin in keloid tissues 
 
IHC labelling revealed that Rspo2 was expressed in the epidermis and 
dermis of both normal skin and keloids (n=7 each group). However, keloids had 
higher expression of this protein in both of these layers compared to normal skin 
(Figure 3.2.10a). 
Active -catenin was not present in normal skin tissues but was expressed 
in the epidermis of keloid tissues, with the strongest expression localized at the 
stratum granulosum region (Figure 3.2.10b). Concurring with previous reports 
(Andriessen et al., 1998; Ehrlich et al., 1994; Ong et al., 2010), it was observed 
that keloid tissues generally exhibit a thickened epidermis, typically at the 
granular and spinous layer, when compared with their normal skin counterparts 















Figure 3.2.10:   Immunohistochemical stain of paraffin representative tissue 
sections of normal skin (NS31) and keloid scar (KS56) probed 
with (a) anti-Rspo2 (b) anti-active β-catenin. For negative 
control, non-immunised mouse antibody (IgG) was used. 
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3.2.8.2 Organotypic skin cultures embedded with NFs transduced with Rspo2 
displayed thickened epidermis 
 
Figures 3.2.11a and 3.2.11b confirmed the stable transduction of 2 lines 
of NF with control lentivirus encoding GFP (EMW) or lentivirus encoding GFP 
and Rspo-2 (EMW-Rspo2). NKs seeded on collagen matrices embedded with 
EMW-Rspo2 fibroblasts formed a thicker epidermis (average 40% increase) 
compared to control fibroblasts (Figure 3.2.12). This was similar to the thickened 
epidermis observed in keloids. 
 
Figure 3.2.11:   Normal fibroblasts transduced with Rspo2 and their controls. 
(a) Fluorescence microscopy of NFM84 stably transfected 
with EMW and Rspo2-EMW constructs respectively. Both 
EMW constructs contain GFP tags which indicate that the 
cells were more than 90% transfected. Scale bar = 100μm. 
(b)Western blot showing expression of Rspo2 in total CLs of 













































Figure 3.2.12:   Hematoxylin-eosin stain of paraffin sections of organotypic 
cultures with fibroblasts (NFM94) transduced with control-
EMW and EMW-Rspo2 constructs embedded in respective 
collagen matrices. NKs (NK0131) were used for seeding for 
the epidermal layer. Scale bar = 100μm. Epidermal thickness 
measurements of organotypic cultures at Day 8 using 
AxioVision software on a Zeiss Axioplan microscope. All 
values represent mean +/- SD with n=6.  Statistical analyses 
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3.2.8.3 Organotypic skin cultures embedded with NFs transduced with Rspo2 
exhibited significant contraction in the collagen lattice only after co-
culture with NKs 
 
It was earlier observed that there was no significant difference in terms 
of area of contraction of the fibroblast-populated collagen gels with control NFs 
(EMW) and NFs transduced with Rspo2 (EMW-Rspo2) in submerged conditions 
2 days after casting the cellular collagen lattices. Interestingly, 3 days after co-
culturing NKs on these FPCLs, also in the submerged condition, the collagen 
matrices embedded with EMW-Rspo2 fibroblasts contracted significantly 
compared to their control (with EMW fibroblasts) matrices  (Figure 3.2.13). 
 
Figure 3.2.13:   (a) Contraction of a representative set of FPCLs 
(triplicates in each group) with fibroblasts (NFM84) 
transduced with control-EMW and EMW-Rspo2 
constructs embedded in respective collagen matrices 
after 3 days. NKs (NK0131) were used for the co-
culturing to obtain the epidermal layer. (b) Percentage 
of initial collagen lattice area at Day 3 after 
keratinocytes co-culture represented by mean +/- SD of 
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5 independent experiments. Statistical analyses were 
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3.3 TREATMENT OF FIBROBLASTS AND KERATINOCYTES 
WITH QUERCETIN 
 
3.3.1 Quercetin inhibited cellular growth and expression of PCNA, β-
catenin and fibronectin in KFs after Wnt3a treatment 
 
MTS assay in Figure 3.3.1a showed that quercetin brought about a 
significant reduction in cellular growth of KFS01 - a line with highest activation 
of Wnt/-catenin signalling, in a dose-dependent manner by day 4 after Wnt3a 
treatment. Similarly, western blot analyses also revealed that quercetin was able 
to mitigate Wnt3a treatment with dose-dependent reduction of fibronectin, -







Figure 3.3.1:   (a) Day-4 MTS assays of a representative line, KFS01 treated 
with control L-cell CM, Wnt3a L-cell CM, Wnt3a L-cell CM 
+ 5μg/ml quercetin and Wnt3a L-cell CM + 20μg/ml 
quercetin; absorbance values represent mean +/- SD of 
quadruplicates. (b) Representative western blot showing 
expression of fibronectin, -catenin, PCNA and GAPDH in 
total CLs of KFS01 treated in the same sequence of culture 
media and reagents shown in part (a). (c) Average relative 
integrated densities of fibronectin/GAPDH, β-
catenin/GAPDH and PCNA/GAPDH expression in western 
blots of NFs and KFs (3 different lines in each group) treated 
with same sequence of culture media shown in part (a); values 
represent mean +/- SD. Statistical analyses were performed 
using one-way Anova- Student-Newman-Keuls Multiple 

















































L-cell CM Wnt3a CM






























































L-cell CM Wnt 3a CM






























3.3.2 Quercetin inhibited cellular growth and β-catenin expression in NKs 
after Wnt3a/Rspo2 treatment 
 
Quercetin at concentrations of 5μg/ml and 20μg/ml significantly 
(p<0.05) inhibited growth of NKs treated with Wnt3a and 50ng/ml of Rspo2 at 
Day 1. However, at Day 3, NKs treated with 5μg/ml of quercetin were able to 
recover from the inhibitory effect of quercetin while those treated at 20μg/ml 
concentration could not (Figure 3.3.2a). The reduction in cellular growth of NKs 
was confirmed by western blot analyses where there was significant 
downregulation of PCNA expression with 20μg/ml of quercetin treatment. Similar 
to KFs, quercetin down-regulated the elevated expression of β-catenin caused by 
the synergistic effects of Wnt3a and Rspo2 in NKs (Figure 3.3.2b) albeit at an 
insignificant level. 
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Figure 3.3.2:   (a) Day-1 and Day-3 MTS assays of a representative line, 
NK0601 treated with control L-cell BKM, Wnt3a BKM, 
Wnt3a L-cell BKM + 50ng/ml Rspo2, Wnt3a L-cell BKM + 
50ng/ml Rspo2 + 5 / 20μg/ml quercetin; absorbance values 
represent mean +/- SD (n=6). (b) Representative western blot 
showing expression of PCNA, -catenin and GAPDH in total 
CLs of NK0601 treated in the same sequence of culture media 
and reagents shown in part (a). (c) Average relative 
integrated densities of β-catenin/GAPDH and PCNA/GAPDH 
expression in western blots of two lines of NKs treated with 
same sequence of culture media shown in part (a); values 
represent mean +/- SD. Statistical analyses were performed 
using one-way Anova- Student-Newman-Keuls Multiple 
Comparisons Test with *p<0.05, **p<0.01 and ***p<0.001. 
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3.3.3 Quercetin inhibited contraction of FPCLs with fibroblasts 
transduced with EMW-Rspo2 and co-cultured NKs 
 
Quercetin was reported to be effective in inhibiting the contraction of 
keloid and hypertrophic scar fibroblasts PCLs (Phan et al., 2003b). As shown in 
Figure 3.3.3, there was inhibition to the higher degree of contraction in FPCLs 
with Rspo2-transduced NFs and co-cultured NKs (Figure 3.2.8.3) after 3 days of 
treatment with 20μg/ml of quercetin. 
Figure 3.3.3:   (a) Contraction of a representative set of FPCL 
(duplicates in each group) embedded with fibroblasts 
(NFM94) transduced with control-EMW and EMW-
Rspo2 constructs and co-cultured with NKs (NK0131). 
Figure depicts co-cultured FPCLs after 3 days of 
treatment with 20μg/ml of quercetin or its vehicle, 
DMSO (b) Percentage of initial lattice area represented 
by mean +/- SD (n=4) after co-cultured  FPCLs were 
treated with 20μg/ml of quercetin or its vehicle. 
Statistical analyses were performed using one-way 
Anova- Student-Newman-Keuls Multiple Comparisons 
Test with *p<0.05. 
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4.1 KFs SENSITIVITY TO WNT3A TREATMENT AND THEIR 
SUPPRESSED EXPRESSION OF SFRP1 : IMPLICATIONS ON 
THEIR HIGH GROWTH AND FIBROTIC PHENOTYPE 
 
There are a growing number of studies which associate the canonical 
Wnt/-catenin signalling to several fibro-proliferative diseases (Bowley et al., 
2007) either due to systemic elevation of Wnt proteins or injury-induced 
suppression of Wnt inhibitors. For example, Cheon et al. (Cheon et al., 2005) 
reported that there was sustained elevated -catenin levels in patients’ 
hyperplastic scar tissue more than 2 years after the initial injury. In another study, 
it was reported that age-related up-regulation of canonical Wnts caused muscle 
stem cells to differentiate towards a fibroblastic lineage, resulting in fibrosis at the 
expense of muscle maintenance (Brack et al., 2007). More recently, 
immunohistochemical examination of lung biopsy samples from patients with 
systemic sclerosis-associated advanced pulmonary fibrosis and in-vitro 
investigation of normal human lung fibroblasts implicated Wnt/-catenin 
signalling to lung fibrosis (Lam et al., 2011). Interestingly, down-regulation of 
SFRPs which are known extracellular antagonists of the Wnt/-catenin signalling 
(Kawano and Kypta, 2003), was also implicated with fibrosis of kidney 
(Surendran et al., 2005) and heart (He et al., 2010; Kaplan et al., 2009). The 
probe for SFRP1 in this study via Q-PCR and western blot studies confirmed its 
loss, both at the mRNA and protein levels in KFs when compared with NFs. 
Firstly, the mRNA data in this study (Figure 3.1.8a) corroborated with the work by 
Smith et al (Smith et al., 2008) which compared KFs with that of normal scar 
fibroblasts, suggesting that silencing of SFRP1 may be important in the fibrosis 
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signature shown by KFs (Russell et al., 2010). This silencing of SFRP1 was 
further demonstrated in this study for the first time that negligible amount of 
SFRP1 was secreted into the CM of KFs compared to NFs (Figure 3.1.8b). 
The subdued amount of secreted SFRP1 by KFs to sequester Wnt 
ligands (Esteve and Bovolenta, 2010) might be one of the explanations for KFs 
being more sensitive to Wnt3a treatment in terms of higher activation levels of -
catenin/TCF activity (Figure 3.1.1), increased expression of -catenin (Figure 
3.1.2) and increased cellular growth (Figures 3.1.3a-b, 3.1.4a-b). While the above 
data for NFs and KFs corroborated with several studies which demonstrated the 
ability of Wnt3a to promote cellular growth and proliferation in murine and 
human fibroblasts/mesenchymal cells through the Wnt/-catenin signalling 
pathway (Baksh and Tuan, 2007; Kim and Choi, 2007; Neth et al., 2006; Shang et 
al., 2007; Torii et al., 2008; Yun et al., 2005), it was further demonstrated here 
that KFs were more susceptible to such exogenous treatment. Similarly, it was 
observed that there was a higher degree of fibronectin up-regulation in KFs 
compared to NFs (Figures 3.1.4a-b) with Wnt3a treatment.  This can be explained 
by the fact that fibronectin is a known Wnt/-catenin signalling target gene in 
mesenchymal cells (Cheon et al., 2005; Gradl et al., 1999; Howard et al., 2003) 
and it is also known to be up-regulated in hyperplastic wounds (Cheon et al., 
2005), hypertrophic scars and keloids (Babu et al., 1989; Kischer and Hendrix, 
1983).  In this study however, there was little or no increase of collagen I in both 
NFs and KFs after Wnt3a treatment (Figures 3.1.4a-b). This data suggested that 
collagen I is not a robust target of Wnt/-catenin signalling in human skin 
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fibroblasts, similar to what was reported in human lung fibroblasts (Lam et al., 
2011). 
Next, it was found that both NFs and KFs did not respond significantly 
to exogenous Wnt3a in terms of FPCL contraction (Figures 3.1.5a-b) and 
migration rate (Figures 3.1.6a-b). Interestingly, a slight decrease in fibroblast 
motility was observed with Wnt3a treatment, albeit at an insignificant level 
(Figure 3.1.6b). The above results were initially unexpected.  Increase in 
fibroblast proliferation, migration and contraction in collagen lattices are 
implicated in keloid pathogenesis (Calderon et al., 1996, Hasegawa et al., 2005, 
Lim et al., 2006). Since KFs were found to be more sensitive to Wnt3a treatment 
in terms of cellular growth earlier in this study, it was speculated that Wnt3a 
would likewise have the same effect on KFs migration and collagen lattice 
contraction. 
However, a recent study on pulmonary fibrosis using lung fibroblasts 
(Lam et al., 2011) also reported that overexpression of active, non-degradable 
form of β-catenin was insufficient to promote fibroblast contraction of type 1 
collagen matrix and while the authors could not find a definitive answer to such a 
phenomenon, one of the conclusions was that contribution of β-catenin signalling 
to lung fibroblast contractility in-vitro may be independent of α-smooth muscle 
actin (α-SMA), a protein known to be implicated with FPCL contraction (Kim et 
al., 2009). Therefore, it can be speculated that the effect of Wnta3a on α-SMA in 
NFs and KFs is negligible, bringing about insignificant FPCL contraction 
compared to control treatment.  
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 Looking into the literature to understand the effect of Wnt3a on NFs 
and KFs migration, it was found that exogenous Wnt3a stimulated motility in 
NIH3T3 (Kim and Choi, 2007), rat bone marrow mesenchymal stem cells (Shang 
et al., 2007) and invasion capacity of  human mesenchymal stem cells (Neth et 
al., 2006). Interestingly, it was also reported that while mouse mesenchymal stem 
cells (mMSCs) responded to Wnt3a treatment in terms of increase in proliferation, 
there was however a corresponding decrease in invasion capacity (Karow et al., 
2009). This impaired invasion phenomenon in mMSCs was attributed in part to 
the down-regulation of membrane type 1-matrix metalloproteinase (MT1-MMP), 
MMP-2 and MMP-9 which, paradoxically, are known Wnt targets in cancer and 
immune cells (Hlubek et al., 2004; Takahashi et al., 2002; Wu et al., 2007).  In 
human lung fibroblasts, while increased -catenin signalling enhanced migration, 
there was no corresponding increase in levels of Wnt targets, MMP-1, 2 and 9. 
These factors are known to be responsible for lung fibroblasts enhanced motility 
and therefore the specific targets of exogenous Wnt3a in this aspect remain to be 
elucidated (Lam et al., 2011).  Taken together, the above studies suggest that the 
targets of Wnt/-catenin signalling are cell-type, tissue-type as well as context 
dependent (Arce et al., 2006). In this current study with KFs, it is speculated that 
Wnt3a might have brought about marginal decrease in MT1-MMP and MMP-2 
expression as these factors are known to influence migration rate in keloids 
(Fujiwara et al., 2005; Imaizumi et al., 2009).   
The stable transduction of SFRP1 in KFs in the current work also 
indirectly helped verify the effects of Wnt3a treatment on them. After it was 
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confirmed that over-expression of SFRP1 brought about reduction in -catenin 
expression (Figure 3.1.9b) in 2 KF lines (KFS01 and KF12), these 2 lines 
correspondingly demonstrated lower cellular growth in MTS assays (Figure 
3.1.10a) as well as lower protein expression of PCNA, cyclin D1 and fibronectin  
(Figures 3.1.10c & 3.1.11a). Similarly, SFRP1 did not seem to have an effect on 
the expression of collagen I in KFs after transduction. While we could not fully 
explain the reason for KFS04’s insensitivity to the forced expression of SFRP1, it 
could partly be attributed to the inherent SFRP1 expression in this line (Figures 
3.1.8b & 3.1.9a). However, PI staining based on GFP-positive population showed 
that the overall viability of the 3 lines transduced with SFRP1 was significantly 
lower than their controls (Figure 3.1.10b). While we cannot discount off-target 
effects of SFRP1, these results suggest that over-expression of SFRP1 worked in 
part through the canonical Wnt/β-catenin pathway by sequestering endogeneous 
Wnt ligands to bring about down-regulation of -catenin. This de-stabilization of 
-catenin in turn brought about a decrease in cellular growth (Figure 3.1.10) and 
fibronectin expression (Figure 3.1.11). 
 
 
4.2 RSPO2 SECRETION FROM EPITHELIAL-MESENCHYMAL 
INTERACTION IN KELOIDS – A DOUBLE PARACRINE 
ACTION 
 
Rspo1 and Rspo2 are known to activate the Wnt/-catenin signalling 
either singly or synergistically with Wnt ligands (Kim et al., 2006). These 
relatively new secreted mitogens were therefore selected as starting candidates for 
this study as it was hypothesized that they might be implicated in keloid 
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pathogenesis. In this current study, Rspo1 and 2 were expressed in fibroblasts of 
both normal skin and keloids (NFs & KFs respectively) at the mRNA level 
however their expression levels were not higher in KFs as was initially postulated 
(Figure 3.2.1a). In addition, RT-PCR data showed that Rspo1 was expressed in 
some NK and KK cultures (Figure 3.2.1b) unlike an earlier study which reported 
no detection of Rspo1 in cultured keratinocytes (Parma et al., 2006). This 
difference could be attributed to variations in the individual’s genetic profile but 
concurring with Parma et al., skin fibroblasts expressed Rspo1 mRNA. However, 
negligible Rspo2 mRNA expression was detected in all NKs and KKs. Due to this 
distinct expression difference between keratinocytes and fibroblasts for Rspo2 
mRNA, further investigation on the expression of Rspo2 for monocultures and co-
cultures of respective NK, NF, KK and KF at the protein level was pursued. But 
more importantly, looking at Rspo2 offered a more definitive model to elucidate 
the possible paracrine signalling between fibroblasts and keratinocytes. The effect 
of epithelial–mesenchymal interactions on Rspo2 was studied via an in-vitro 
double chamber co-culture model. 
KF and KK monocultures were found to have higher protein expression 
of intracellular and secreted Rspo2 as compared to their normal counterparts. In 
the co-culture system, it was found that KKs upregulated intracellular Rspo2 in 
NFs and KFs as compared to NKs.  Increased secretion of Rspo2 was evident in 
the CM of KK-NF as negligible Rspo2 was detected in CM of individual 
monocultures of KK and NF (Figure 3.2.4). As for the CM of NK-NF 
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combination, marginal traces of Rspo2 were detected. Taken together, the results 
indicate that Rspo2 might have a role in the pathogenesis of keloids. 
While it was shown in the earlier part of this study that Wnt3a increased 
cellular growth in both NFs and KFs with corresponding increase in -catenin 
expression and activation (Figures 3.1.1-3.1.2), it was found that exogenous 
Rspo2 alone did not induce cellular growth in NFs and KFs (Figure 3.2.6a). 
Similarly, there was no significant change in protein expression of β-catenin, 
fibronectin, collagen I, PCNA, cyclin D1 and even VEGF in two lines of NF 
(NFM84 and NFM94) after Rspo2 transduction, compared to their controls 
(Figure A2 in Appendix). When rhRspo2 was used in conjunction with Wnt3a, a 
slight elevation in cellular growth of both NFs and KFs was observed (Figure 
3.2.6a). Once again, KFs were found to display a significant increase in cellular 
growth (p<0.05) after such a combined treatment, concurring with earlier finding 
that they are more sensitive to Wnt/β-catenin signalling. However, taken together, 
the above data suggested that fibroblasts were not sensitive to isolated treatment 
of Rspo2 in terms of up-regulation of proliferative and fibrotic factors. Rspo2’s 
function seemed to be confined as an adjunct to Wnt3a in these mesenchymal 
cells. 
Nevertheless, skin keratinocytes were found to respond to Rspo2 alone 
as this protein elicited an increase in proliferation of NKs in a dose dependent 
fashion and there was significant synergistic effect with Wnt3a to bring about 
enhanced proliferation (Figures 3.2.6b-d). This finding corroborated with recent 
reports where Rspo proteins were found to have mitogenic influence in intestinal 
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epithelium (Kim et al., 2005) as well as mucosal epithelial cells (Zhao et al., 
2009). Rspo was also found to be necessary for maintaining epidermal 
homeostasis, growth and differentiation in an organotypic culture of the skin but it 
did not bring about any change in the pathological phenotype of cultured 
fibroblasts (Parma et al., 2006).  
In the current study, it was demonstrated that Rspo2 activated the 
Wnt/β-catenin signalling pathway in cultured NKs and it acted synergistically 
with Wnt3a to activate this pathway (Figures 3.2.7a-b) through phosphorylation 
of co-receptor LRP6 (Figure 3.2.7c). This phosphorylation effect was inhibited by 
Wnt inhibitor, Dkk1 - agreeing with recent studies of Rspo treatment of 
HEK293T (Wei et al., 2007) and C2C12 cells (Lu et al., 2008). It was reported 
that Rspo proteins regulated the canonical Wnt signalling pathway by a common 
mechanism as they required Wnt ligands and LRP6 for activity  in HEK293T 
cells (Kim et al., 2008).   
The use of Wnt inhibitor, Dkk1 and silencing of β-catenin (Figures 
3.2.6b and 3.2.9) further suggested that induction of NK proliferation by Rspo2 
and its synergistic effect with Wnt3a were mediated through the Wnt/β-catenin 
pathway. The association of β-catenin with human keratinocyte proliferation was 
previously reported. It was found that the subpopulation of cultured human 
keratinocytes with high proliferative potential had a larger pool of noncadherin-
associated β-catenin than transit-amplifying cells (Zhu and Watt, 1999). It was 
also demonstrated that non-confluent, proliferating HaCaT cells (a human 
keratinocyte cell line) contained an increased cytoplasmic pool of β-catenin 
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compared to its confluent, contact-inhibited counterparts (Dietrich et al., 2002).  
Furthermore, exogenous Wnt3a was reported to induce proliferation in human 
skin epidermal stem cells (Jia et al., 2008) and HaCaT cells (Kitagawa et al., 
2009; Memezawa et al., 2007). 
Our double chamber co-culture experiments pointed to the possible 
double paracrine signalling (Maas-Szabowski et al., 1999; Werner et al., 2007) 
initiated by KKs to induce secretion of Rspo2 in fibroblasts. In turn, these 
secreted Rspo2 proteins stimulated KK growth, most likely in combination with 
endogenous Wnt ligands present in the system. The induction of Rspo2 secretion 
by this keratinocyte-fibroblast interaction of the keloid cells might be one of the 
contributing factors for the epidermal activation and thickening of keloids’ 
epidermis. Keloids/hypertrophic scars were previously reported to have thickened 
epidermal cell layers (Kischer et al., 1982) which were found to express 
hyperproliferative keratins K6/K16 (Machesney et al., 1998; Ong et al., 2010) as 
well as higher levels of Ki-67 at the basal layer (Andriessen et al., 1998). In IHC 
analysis conducted in this current study, the thickened epidermis of keloids was 
found to express active β-catenin but not so in normal skin (Figure 3.2.10b). 
Similarly, IHC analyses also revealed that Rspo2 expression was higher in both 
the epidermis and dermis of keloids compared to normal skin (Figure 3.2.10a). 
The higher IHC expression of Rspo2 observed in the epidermis of both normal 
skin and keloid, relative to the expression of NKs or KKs seen in RT-PCR and 
western blots, could be attributed to non-specific binding of the polyclonal Rspo2 
Ab in the tissues. 
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Taken together, it is plausible to suggest that the higher expression of 
Rspo2 in keloids - either due to their endogenous levels or as a result of epithelial-
mesenchymal interactions, account in part for their hyperproliferative and 
thickened epidermis, mediated by Wnt/ β-catenin signalling. This hypothesis was 
partially confirmed by the observation of NKs forming a thicker epidermis when 
cultured with NFs stably expressed with Rspo2 in an organotypic skin co-culture, 
when compared with its control (Figure 3.2.12).  Interestingly, a recent study 
showed that NKs formed thicker epidermis when co-cultured with KFs in an 
organotypic culture (Butler et al., 2008b). In immunochemical analyses of the 
organotypic skin, while expression of active β-catenin and Ki67 were found in the 
epidermis of both cultures (one with overexpressed Rspo2 NFs and the other, its 
control), there was no significant difference in the expression between these two 
groups (Figures A3 and A4 in Appendix).  This is possibly due to the inherent 
hyperproliferative or activated phenotype of epidermis in the cultured organotypic 
skin (Smiley et al., 2005; Smiley et al., 2006). 
In addition it was also found that the FCPLs embedded with fibroblasts 
transduced with Rspo2 contracted significantly only with the co-culture of NKs 
(Figure 3.2.13), a phenomenon which is synchronous to the higher degree of 
contraction by KFs in FCPLs compared to NFs (Figure 3.1.5b and Phan et al., 
2003d). This data again reinforces the hypothesis that epithelial-mesenchymal 
interactions as one of the factors responsible for keloid pathogenesis in terms of 
contraction even as NFs transduced with Rspo2 did not express higher 
proliferative and fibrotic factors (Figure A2). 
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Until now, it was not possible to conclude whether the observed 
epidermal activation in keloids/hypertrophic scars was a mere consequence of 
scar formation itself, or was causally involved in the pathogenic process 
(Andriessen et al., 1998).  However, as we increasingly recognize the important 
role of KKs in keloid pathogenesis through epithelial-mesenchymal interactions 
(Butler et al., 2008b), what can be concluded from the current study is that 
secretion of Rspo2 from fibroblasts as a result of induction by KKs, is possibly 
one of the factors which sustains the activated phenotype of the thickened 
epidermal layer of the keloids through the Wnt/β-catenin pathway and via a 
double paracrine action. This activated keloid epidermis in turn stimulates the 
underlying dermal layer to be fibroproliferative and more contractile in a 
continuous feedback loop, supporting each other’s functions. 
 
 
4.3 QUERCETIN TARGETS THE WNT/-CATENIN PATHWAY IN 
KFs and NKs - A POSSIBLE THERAPEUTIC OPTION FOR 
KELOID TREATMENT? 
 
Quercetin was previously reported to inhibit growth in colon cancer 
(Park et al., 2005) and leukaemia (Kawahara et al., 2009) cell lines through the 
Wnt/-catenin pathway. In this study, quercetin was found to mitigate the 
increase in cellular growth of both KFs and NKs after Wnt3a treatment (with or 
without rhRspo2), in a dose-dependent fashion based on MTS assays, and seen in 
the decrease in PCNA expression (Figures 3.3.1a-c and 3.3.2a-b). Similarly, there 
was a corresponding decrease in -catenin expression in both KFs and NKs after 
Wnt activation as determined by western blots (Figures 3.3.1b-c and Figure 
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3.3.2b).  The above data suggest that quercetin, a multi-target or broad spectrum 
kinase inhibitor (Kerr and La Thangue, 2004), either directly or indirectly targets 
the Wnt/-catenin pathway in KFs and NKs. In addition, quercetin was able to 
significantly reduce the elevated level of fibronectin (a known Wnt target) in KFs 
after Wnt3a treatment (Figure 3.3.1b) and prevent the increased contraction of 
FPCLs which were embedded with Rspo2-tranduced fibroblasts and co-cultured 
with NKs (Figure 3.3.3). Taken together, quercetin is found to be a suitable 
candidate in mitigating the effects of increased canonical Wnt signalling in 
keloidic cells as a result of suppressed SFRP1 and elevated Rspo2 expression 
shown in the current study. Furthermore, quercetin was able to inhibit the 
contractile effect of epithelial-mesenchymal interactions (where Rspo2 is 
implicated) in the FPCL system representative of the keloid model (Figure 3.3.3). 
Therefore, quercetin can be a possible therapeutic option for keloid treatment as a 















































5.1 GENERAL CONCLUSION 
 
An achievement of this research work is that it has demonstrated and 
verified that the canonical Wnt/β-catenin signalling is of one of the modulators of 
keloid pathogenesis. While there were previous publications to implicate this 
canonical pathway with keloid formation (Sato 2006, Smith et al.,2008; Russel et 
al., 2010), these publications did not totally provide evidence as to how direct 
activation and attenuation of the canonical Wnt signalling pathway could affect 
cellular growth, FPCL contraction and changes to fibrotic factors in keloidic cells 
or in their equivalent co-culture model. In this study, the approach was to use 
primary fibroblasts and keratinocytes derived from normal skin and keloids either 
as a monoculture or co-cultured system, to probe for players involved in the 
regulation of Wnt/-catenin signalling. These components found were in turn 
tested to determine if they were associated with keloid pathogenesis. 
In the first part of this study, it was found that KFs were more sensitive 
to Wnt3a treatment compared to NFs in terms of increased activation of Wnt/β-
catenin signalling which correspondingly led to elevated cellular growth and 
fibronectin expression in KFs. This study also verified for the first time at the 
protein level that KFs secrete less SFPR1 relative to NFs. SFRP1 is known to 
inhibit the canonical Wnt signalling by sequestering Wnt ligands in the extra-
cellular region. Therefore, KFs sensitivity to Wnt3a treatment might be due to 
their lower amount of inherent SFRP1 ligands present to mitigate the canonical 
effects of endogenous Wnt ligands. Indeed, stable transduction of SFRP1 in KFs 
resulted in attenuation of β-catenin signalling with corresponding reduction in 
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cellular growth and fibronectin expression. Interestingly, no significant change in 
collagen I expression, FPCL contraction and cell migration were observed in KFs 
after Wnt/β-catenin activation by Wnt3a, unlike what was reported in other cell 
types. One of the reasons speculated for these phenomena was that collagen I is 
not a robust target of Wnt signalling as seen in human lung fibroblasts (Lam et 
al., 2011). Figures 5.1a-b summarise the suggested scenarios described above 
with respect to the interaction between SFRP1 and possible endogenous Wnt 
ligands in NFs and KFs. The common thread which resulted in changes to cellular 
growth and fibronectin expression after direct activation (Wnt3a treatment) and 
attenuation (transduction of SFRP1) of the canonical Wnt signalling, suggested 
that keloid pathogenesis is mediated by this pathway, along with the well-known 
TGF- and IGF pathways. 
In the second part of this study, the protein expression and secretion of 
Rspo2, a relatively new protein known to be a Wnt/-catenin signalling agonist, 
were found to be elevated in monocultures of KFs and KKs when compared to 
their normal counterparts. Double-chamber co-culture implicated the role of KKs 
in the induction of Rspo2 secretion from fibroblasts because of epithelial-
mesenchymal interactions. Interestingly, NFs and KFs did not respond to 
exogenous Rspo2 treatment alone and neither was there a phenotypical change in 
NFs towards a proliferative or fibrotic nature after Rspo2 stable transduction. 
However, recombinant Rspo2 in culture increased proliferation of NKs and it 
acted synergistically with Wnt3a through the canonical Wnt/-catenin pathway. 
In addition, NFs transduced with Rspo2 induced growth of a thicker epidermis as 
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compared to control fibroblasts in a skin organotypic co-culture model. It was 
also observed that the collagen lattices populated with Rspo2-transduced NFs 
contracted significantly compared to its control only after co-culture with NKs. 
The above two observations coincide with phenotypes associated with keloids. 
Firstly, keloids were reported to have thickened epidermis with hyperproliferative 
phenotype (Ong et al., 2010) and secondly, KFs in FPCL were known to contract 
more significantly compared to NFs (Phan et al. 2003d). The fact that this higher 
degree of contraction can be reproduced only with the combination of normal 
keratinocytes and fibroblasts- overexpressed with Rspo2 in an organotypic model, 
strongly suggests the important role of epithelial-mesenchymal interactions in 
keloid pathogenesis. And indeed, even though much of the literature points to the 
fibroblast as the main culprit in keloid pathology, the current work adds to the 
increasing evidence that histologically normal-appearing keratinocytes interact 
with the fibroblasts to stimulate keloid formation (Butler at al., 2008a). 
Further to that, this work has for the first time implicated the double 
paracrine action of KKs where these cells induced the secretion of Rspo2 from 
fibroblasts. These secreted Rspo2 proteins sustain the activated phenotype of 
thickened epidermal layer in keloids which in turn stimulate the underlying 
dermis to be proliferative and fibrotic in a continuous feedback loop, supporting 
each other’s growth. Figure 5.2 depicts the possible double paracrine mechanism 
with the involvement of Rspo2 in keloid scarring. 
Finally, it was demonstrated for the first time that quercetin was able to 
mitigate the elevated Wnt signalling in KFs by targeting β-catenin. This is on top 
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of what is known of quercetin which was reported to target TGF-β and IGF 
signalling pathways in keloid scarring. Therefore, it could be speculated that 
quercetin also inhibited the double paracrine actions by targeting the pathways 
responsible for keloid pathogenesis as well the mechanism where Rspo2 is 
involved. This was evident from the smaller degree of contraction observed in co-
cultured organotypic skin cultures embedded with Rspo2-tranduced fibroblasts 
compared to their control, after quercetin treatment. While quercetin is further 
proven to be a suitable candidate for keloid treatment or prevention, the 
underlying take-home message in this entire study is that for any future 
therapeutic agents developed to treat this fibrotic disease, targeting the canonical 
Wnt/β-catenin pathway has to be taken into account as well. 
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Figure 5.1:   Schematic diagram of suggested canonical Wnt signalling with 
its interaction with SFRP1 in (a) NFs and (b) KFs. Due to 
negligible secretion of SFRP1 in KFs, there is elevation of Wnt 
signalling which partly contributes to keloid pathogenesis.                   
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Figure 5.2:   Proposed double paracrine signalling in keloid scarring with 
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5.2 FUTURE DIRECTION 
 
The current study has also raised several interesting new themes and 
future directions which are listed and described below. 
 
5.2.1 Cross-talk of Wnt/-catenin signalling with other pathways in keloid 
pathogenesis 
 
While the current study has focused on the role of the canonical Wnt 
pathway in keloid pathogenesis using skin fibroblasts and keratinocytes, it would 
be interesting to investigate if the direct activation of Wnt signalling results in 
activation or attenuation of other signalling pathways. While Sato reported that 
TGF-β induced the up-regulation of Wnt/β-catenin signalling in KFs (Sato, 2006), 
there was another report which found that Wnt3a induced up-regulation of 
mRNAs encoding potent pro-fibrotic proteins such as TGF-β and endothelin-1 
(ET-1) in NIH3T3 fibroblasts (Chen et al., 2007).. Therefore, there is a possibility 
of a reverse induction with Wnt activating the TGF-β pathway in KFs. Previously, 
crosstalk between TGF-β and Wnt pathways was reported to be regulated by 
Smads (Letamendia et al., 2001) while transcriptional cooperation between these 
two pathways were found in mammary and intestinal tumorigenesis (Labbe et al., 
2007). In addition, Wnt signalling in mammary epithelial cell line (Matsuda et al., 
2009) and NIH3T3 (Yun et al., 2005) was found to activate the extracellular 
signal-regulated kinase (ERK) pathway. ERK signalling is known to be elevated 
in keloids (Lim et al., 2003) and similarly it would be interesting to know if Wnt 
signalling activate the ERK casacde in KFs. Finally, it would also be useful to 
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determine if SFRP1 has any effect on KFs via the non-canonical Wnt pathway 
and other pathways. 
 
5.2.2 Signalling from KKs which activates Rspo2 secretion from 
fibroblasts 
 
The current study has demonstrated that the presence of KKs in double 
chamber co-culture experiments triggers the secretion Rspo2 from fibroblasts, 
which in turn promotes keratinocyte proliferation and epidermal thickening in a 
double paracrine fashion (Figure 5.2). However, it is not known what kind of 
signalling is communicated by KKs to fibroblasts to trigger the release of Rspo2. 
A possible approach is to screen out outstanding proteins secreted by KKs 
(relative to NKs) using a comparative proteomic study and test if these proteins- 
used either in isolation or in combination, trigger Rspo2 release from fibroblasts.  
 
5.2.3 Study of interplay between MMPs and tissue inhibitors of 
metalloproteinases (TIMPs) which affects cell migration after 
Wnt/β-catenin activation 
 
In this study, the cell migration data of NFs and KFs after Wnt3a 
treatment were unexpected as there was no significant increase in migration rate 
unlike what was observed in many cancer cell lines as well as human 
mesenchymal stem cells. In fact, a slight decrease in migration rate was observed 
in both NFs and KFs (Figure 3.1.6).  The interplay between MMPs and TIMPs is 
known to affect KFs migration rate (Fujiwara et al., 2005) and MMPs are 
reported to be targets of Wnt signalling in certain cell types. It would therefore be 
worthwhile to investigate the expression changes of MMPs and TIMPs after 
Wnt3a treatment to better elucidate the mechanism of migration in KFs. 
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5.2.4 Development of quercetin-based cream and patches for the clinical 
treatment of keloid scarring 
 
While quercetin cream is sold in the market as a cosmetic and anti-aging 
product, there is currently no known quercetin-based cream or patch used 
clinically to treat keloid scarring. Quercetin was demonstrated to have inhibitory 
effects on primary keloid cell cultures not only through the Wnt/β-catenin 
pathway shown in this study but also through the TGF-β and IGF signalling 
pathways (Phan et al. 2003c, Phan et al., 2004). It is therefore timely to work 
towards the development of a clinical quercetin-based cream or transdermal patch 
to be tested in in-vivo models before going towards clinical trials. 
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Figure A1 Luciferase activity of HEK293T co-transfected with reporter gene 
constructs with TOPflash (0.5μg) or its mutant FOPflash (0.5μg) 
and β-galactosidase plasmid (0.1μg) as an internal control. Ratios of 
luciferase/ β-galactosidase activities after different treatment 
regimes represent β-catenin/T-cell factor (TCF)-induced 




























































































Figure A2:   Western blot showing expression of fibronectin, collagen I, β-catenin, 
VEGF, cyclin D1, PCNA and GAPDH in cell lysates of NFM84 and 














































Figure A3: Immunohistochemical probe for anti-active β-catenin in paraffin 
sections of organotypic cultures with fibroblasts (NFM94) 
overexpressed with control-EMW and EMW-Rspo2 constructs 
embedded in respective collagen matrices. NKs (NK0131) were used 
for seeding for the epidermal layer. For negative control, non-
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Figure A4: Immunostaining for Ki67 (in pink) in cryosections of organotypic 
cultures with fibroblasts (NFM84) overexpressed with control-EMW 
and EMW-Rspo2 constructs embedded in respective collagen 
matrices. NKs (NK0131) were used for seeding for the epidermal 
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Table A2 Sequence alignments and result summary for human Rspo2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
